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Quantitative GTPase Affinity Purification
Identifies Rho Family Protein Interaction
Partners*□S
Florian Paul‡, Henrik Zauber‡, Laura von Berg§, Oliver Rocks§, Oliver Daumke¶,
and Matthias Selbach‡
Although Rho GTPases are essential molecular switches
involved in many cellular processes, an unbiased experi-
mental comparison of their interaction partners was not
yet performed. Here, we develop quantitative GTPase af-
finity purification (qGAP) to systematically identify inter-
action partners of six Rho GTPases (Cdc42, Rac1, RhoA,
RhoB, RhoC, and RhoD), depending on their nucleotide
loading state. The method works with cell line or tissue-
derived protein lysates in combination with SILAC-based
or label-free quantification, respectively. We demonstrate
that qGAP identifies known and novel binding partners
that can be validated in an independent assay. Our inter-
action network for six Rho GTPases contains many novel
binding partners, reveals highly promiscuous interaction
of several effectors, and mirrors evolutionary relation-
ships among Rho GTPases. Molecular & Cellular Pro-
teomics 16: 10.1074/mcp.M116.061531, 73–85, 2017.
The Ras superfamily of small guanosine triphosphatases
(Ras GTPases) consists of more than 150 members in mam-
mals and conserved orthologs in all eukaryotes (1). As molec-
ular switches, they cycle between an active GTP- and an
inactive GDP-bound state. GTPase-activating proteins
(GAPs)1 stimulate the slow intrinsic GTPase activity, which
inactivates the GTPase. Conversely, guanine nucleotide ex-
change factors (GEFs) promote release of GDP, which is
replaced by GTP, thereby transforming the GTPase into the
active state. The GTP-bound form binds to downstream ef-
fector proteins to initiate their specific cellular function. In
this manner, GTPases control numerous biological pro-
cesses, including cytoskeletal rearrangements, membrane
dynamics, and gene expression. Rho GTPases form a sub-
family of the Ras superfamily (2). Of its 22 mammalian mem-
bers, RhoA, Rac1, and Cdc42 have been studied most inten-
sively and are best known for their role in regulating the actin
cytoskeleton (3).
Identifying effector proteins is key to understanding Rho
GTPase function. More than 70 effector proteins have already
been identified for each of the three prototypical family mem-
bers, RhoA, Rac1, and Cdc42 (4). However, new effector
proteins are still being discovered, and little is known about
effectors of less well studied family members. Systematic
screens for GTPase effectors employed the yeast two-hybrid
approach (5) or immobilized GTPases for affinity purification
(6, 7). However, these approaches are semiquantitative at
best, which makes it difficult to distinguish loading-state-
specific binders from constitutive interactors and nonspecific
contaminants. Due to these challenges, an unbiased interac-
tor screen for multiple Rho GTPases has not yet been
reported.
We sought to systematically identify proteins that interact
with Rho GTPases in a loading-state-specific manner. Quan-
titative affinity purification combined with mass spectrometry
is a powerful technology that can be used to identify protein–
protein interactions (PPIs) in an unbiased way (8–11). Here,
we develop quantitative GTPase affinity purification (qGAP) as
a novel variant of quantitative affinity purification combined
with mass spectrometry to systematically identify Rho
GTPase interaction partners. We then employ qGAP to screen
for interaction partners of the three prototypical Rho GTPases
(Cdc42, Rac1, RhoA) and three additional family members
(RhoB, RhoC, RhoD). We employ qGAP in a SILAC-depend-
ent way with lysates of cultured cells (SILAC-qGAP) and a
label-free manner (LF-qGAP) with tissue samples. We show
that qGAP identifies many well-known effectors and dozens
of potential new interaction partners. Importantly, new inter-
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action partners can be validated with a high success rate in an
independent assay. Our interaction network reflects evolu-
tionary relationships among Rho GTPases and reveals pro-
miscuous binding of several known effectors.
RESULTS
Establishing SILAC-qGAP—Quantitative affinity purification
combined with mass spectrometry can be used to study
cellular dynamics of PPIs (8, 9, 11–13). The principle is to
compare the abundance of proteins copurifying with the bait
to an internal control. The approach can thus distinguish
specific interaction partners from nonspecific contaminants:
While true interaction partners are more abundant in the bait
sample, nonspecific contaminants show a 1:1 ratio. This strat-
egy has been successfully employed to identify both consti-
tutive PPIs and dynamic PPIs that are regulated by cellular
signaling events and/or posttranslational modifications
(14–17).
We reasoned that quantitative affinity purification combined
with mass spectrometry should also allow us to identify
GTPase effector proteins in an unbiased manner (Fig. 1 A).
To establish the method, we recombinantly expressed Rho
GTPases as GST-fusion proteins in Escherichia coli and pu-
rified them to homogeneity. In order to test whether or not
purified recombinant GTPases were enzymatically active, we
initially monitored the intrinsic GTPase activities of RhoA,
Cdc42, and Rac1 by an HPLC-based method. All three Rho
GTPases showed GTP-hydrolysis activity (Fig. S1) with rate
constants similar to previously published data (18–21). To
further evaluate their functionality, we added HEK cell lysates
to the reactions overexpressing citrine-labeled GAPs specific
for each GTPase (22–24). Lysates of citrine-expressing con-
trol cells increased GTP hydrolysis, presumably due to the
presence of endogenously expressed GAPs in the lysate (Fig.
S1). The presence of citrine-labeled GAPs dramatically in-
creased GTP hydrolysis (Fig. S1). These data clearly show
that the purified recombinant GTPases used in our experi-
ments were fully active and capable of interacting with known
interaction partners.
In order to test whether or not we can identify activation
state-specific binders, we loaded recombinant Cdc42 with
GDP or GTPS, a GTP-analog that is inefficiently hydrolyzed
(25). Differentially loaded fusion proteins were then covalently
coupled to N-hydroxysuccinimide-activated Sepharose beads.
These beads were used to pull-down interacting proteins from
differentially SILAC-labeled HeLa cell lysates. After washing,
proteins were combined, eluted, and analyzed by high reso-
lution shotgun proteomics and MaxQuant (26). In total, we
identified over 1,000 proteins (Fig. 1B). As expected, the vast
majority of these proteins had SILAC log2 fold changes
around 0, indicating that they do not interact with Cdc42 in a
loading-state-specific way. We then selected significant out-
liers in the distribution of log2 fold changes as putative spe-
cific interaction partners of the GTP- and GDP-loaded forms
(calculation with the software package Perseus, “significance
B,” Benjamini Hochberg false discovery rate 5% (26)). Most
of these putative binders showed preferential interaction with
the GTPS-loaded form. This is consistent with the idea that
the GTP-bound form mediates most downstream functions
(27, 28). As an additional control, we also performed a label
swap experiment (Fig. 1C). We then plotted the log2 fold
changes from both experiments against each other (Fig. 1D).
Specific binders were required to be significant outliers in
both experiments and to show inverted ratios. Note that the
same heavy and light lysates were used for both the forward
and reverse experiment. Therefore, requiring an inverted ratio
in the label swap eliminates proteins that deviate from the 1:1
ratio already in the lysate. According to these criteria, 25
proteins were defined as loading-state-specific binders. All of
them showed preferential binding to the GTPS-loaded form.
The list contains several well-known Cdc42 interactors like
Cdc42 binding proteins (CDCBPA and CDC42BPB), Cdc42
effector proteins (CDC42EP1, 2, 3, and 4) as well as BAIAP2.
Collectively, these data indicate that our assay can reliably
identify Cdc42 effectors.
Establishing LF-qGAP—One limitation of the experiments
described above is that they are based on lysate derived from
HeLa cells. Hence, proteins that are not expressed in this cell
line cannot be detected. We therefore sought to employ lysate
derived from tissues as broader source of proteins for our
qGAP assay (Fig. 2A). We chose mouse brain lysate since five
of the six Rho GTPases studied here are expressed in this
tissue (only RhoC seems to be expressed in macrophages or
glandular cell types (29)). In addition, different cell types are
present in brain, which should lead to a large number of
potential binding proteins being available in the lysate. For
quantification, we chose a label-free approach that was used
previously to study interaction partners of GFP-fusion pro-
teins (30, 31).
To test the performance of (LF-qGAP, we repeated pull-
downs with Cdc42 using protein lysate prepared from mouse
cerebellum (Figs. 2A and 2B). In total, we performed six
pull-downs—three with the GDP-loaded form and three with
the GTPS-loaded form. After proteomic analysis of all six
samples, we used label-free quantification by MaxQuant (32)
and displayed the data as a volcano plot (Fig. 2B). We ac-
cepted proteins as loading-state-specific binders based on a
combination of the t test p value and the fold change at a
permutation-based false discovery rate of 0.05 (30). In total,
these experiments identified 42 and two potential interactors
of the GTPS- and GDP-loaded form, respectively. The in-
creased number of identified interaction partners compared
with the SILAC data (Fig. 2C) is probably due to a combination
of technical (experimental setup, data analysis) and biological
factors (different protein levels, cofactors, and posttransla-
tional modifications). For example, we observed that interac-
tion partners that we exclusively found in brain tissue pull-
downs tend to be more abundant in brain tissue than in HeLa
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cell lysate (data not shown). Thus, LF-qGAP is not necessarily
superior to the SILAC-qGAP. The choice of the lysate should
generally be guided by the biological question.
LF-qGAP for Six Rho GTPases—Encouraged by these re-
sults, we used LF-qGAP to screen for interaction partners of
Rac1, Cdc42, RhoA, RhoB, RhoC, and RhoD (Fig. 3 and Fig.
A
























































































































































































































FIG. 1. Identification of Cdc42 interaction partners with SILAC-qGAP. (A) Rho GTPases were expressed, purified, loaded with either GDP
or GTPS, and bound to a Sepharose matrix. Protein samples were obtained from SILAC-labeled cells. Proteins from H- and L-labeled cells
were pulled down with Cdc42GTPS and Cdc42GDP in a forward (arrows) and reverse experiment. Bound proteins were eluted and analyzed
via mass spectrometry. Significant outliers were calculated (labeled in orange) for the forward (B) and reverse (C) experiment. Proteins that are
significant outliers in the forward and reverse experiment and that were specific to one nucleotide form in both experiments are considered
specific interaction partners of Cdc42 (D, labeled in orange).
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S2). For Rac1, Cdc42, and RhoA, we also used lysates de-
rived from different brain regions (cerebellum, cerebrum, and
hippocampus) while whole brain lysates were used for RhoB,
RhoC, and RhoD. Every experiment was performed in biolog-
ical triplicates. We performed ten experiments (six Rho
GTPases and varying brain tissues) with six pull-downs for
each experiment (three replicates for GDP and GTP each, i.e.
a total number of 60 individual pull-downs). From these, we
generated an unbiased map of Rho GTPase interaction part-
ners. For each GTPase, we identified between 24 and 73
potential interactors. In total, this amounted to 293 interac-
tions (Supplemental Table 1). Most of them were specific for
the GTPS-loaded form, consistent with the idea that the
GTP-loaded form mediates most downstream functions.
Many of the proteins we identified as GTPS-specific binders
are well-known effectors (like N-WASP for Cdc42, Rhotekin
for RhoA and RhoB) while others are novel (such as mitotic
spindle organizing protein 2 for Cdc42). Similarly, some of the
GDP-specific interactions are known (e.g. Tiam2-Rac1) and
some are new (e.g. Traf7-Rac1).
The analysis above is based on the direct comparison of
the GTPS and the GDP-loaded form of an individual Rho
GTPase. While this is the most relevant control strategy, we
would like to point out that our data can be analyzed in
different ways. For example, differences in interactors be-
tween GTP-loaded forms of two different GTPases could be
identified by directly comparing them to each other (e.g.
Rac1- GTPS with Cdc42-GTPS).
Comparison to Published Data—To systematically compare
our data with known interactors, we used an integrated pro-
tein interaction database, HIPPIE, as a reference (33). We
found that known targets are highly significantly overrepre-
sented in our dataset (Fig. 4, p values between 7  104 and
3  1031, p(X  x), hypergeometric test). Since several
literature-described Rho GTPase interaction partners are not
in the reference database (e.g. Plekhg5 for RhoA (34) and
Arhgap5 for Rac1 (35)) but were identified in our screen, we
expect the number of true positive identifications of qGAP to
be even higher. In addition, our data also contain proteins that
are probably indirect binders. For example, we found associ-
ation of lethal giant larvae homolog 1 with Cdc42, which is
probably mediated via the complex of PAR-6A and atypical
protein kinase C (aPKC-lambda/iota) that were also both iden-
tified. Whether or not detection of indirect interactors is a
strength or weakness is a matter of perspective. In any case,
our data show that qGAP hits are highly enriched for proteins
involved in Rho GTPase biology.
Validation—For each Rho GTPase, we identified dozens of
novel interaction partners (see also colored lines in Fig. 6A).
Thus, our dataset provides a valuable resource for exploring
Rho GTPase biology. However, since qGAP is an in vitro
assay, it is not clear if identified potential interactors also
associate with their respective Rho GTPase in living cells. We
therefore sought to validate qGAP hits using an independent
method. Ideally, this method should (i) assess interactions of
endogenous untagged proteins in vivo, (ii) provide an unbi-
A
































































FIG. 2. Identification of Cdc42 interaction partners with LF-qGAP from mouse cerebellum. (A) Protein lysates from mouse cerebellum
(n  3 independent samples) were incubated with Cdc42GTPS or Cdc42GDP coupled to beads. Bound proteins were eluted and analyzed
via mass spectrometry in triplicates. Differences in intensities between runs (Log2 Cdc42GTPS/Cdc42GDP) and statistical significance
(-Log10(p value t test)) were calculated. (B) Specific interactors are distinguished from background proteins based on a combination of the log2
fold change and the t test p value (significantly different proteins in orange), Cdc42GTPS (right) or Cdc42GDP (left) (colored in red). (C) We
identified more interaction partners for LF-qGAP (44 proteins) than for SILAC-qGAP (25) with a significant overlap (15).
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FIG. 3. LF-qGAP from brain lysates for six Rho GTPases. Cerebrum pull-downs for (A) Cdc42, (B) Rac1, (C) RhoA. Pull-downs from whole
brain lysates for (D) RhoB, (E) RhoC, (F) RhoD. As before, specific interactors (colored in orange) are distinguished from background proteins
based on a combination of the log2 fold change and the t test p value. GTPS-specific interactors are expected in the upper right corner,
interactors of the GDP-form in the upper left corner.
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ased quantitative read out, and (iii) differentiate between the
GTP- and the GDP-loaded form of the Rho GTPase. The
proximity ligation assay (PLA) uses oligonucleotides attached
to antibodies against two target proteins that guide the for-
mation of circular DNA strands when bound in close proximity
(36). The DNA can be amplified and visualized, which enables
unbiased quantification of endogenous protein complexes at
single-molecule resolution. The GTP-loading state of endog-
enous Rho GTPases can be manipulated with the bacterial
toxins CNFY and CNF1 (37, 38). These toxins deamidate a
single glutamine residue that is required for GTPase activity.
Thus, toxin treatment locks the endogenous Rho GTPases in
the GTP-bound state. CNF1 targets RhoA at Gln63 and Rac1
and Cdc42 at Gln61 while CNFY is specific for RhoA (39–41).
We reasoned that combining PLA with CNF1 or CNFY treat-
ment should allow us to validate qGAP interaction partners in
situ. HeLa cells were serum starved, treated with the toxin or
vehicle control for 1 h, and fixed. We then used PLA to assess
the proximity of Rho GTPases with identified interaction part-
ners using specific antibodies. The PLA signal between RhoA
and the known effector Rho-associated protein kinase 2
(Rock2) increased upon toxin treatment, indicating that Rock2
associates with activated RhoA (Fig. 5A, left). Rock2 was
originally described to be specific for RhoA (42). Interestingly,
qGAP also detected association of Rock2 with Rac1 and
Cdc42, and this was validated by our PLA-based approach
(Figs. 5A center and 5B). PLA also validated interaction of
Cdc42 with IQSEC3 (Fig. 5A, right). In total, our PLA-based
method validated 9/11 tested novel interactions (Fig. 5B and
Fig. S3). The data suggest that most of the novel qGAP
interactors also associate with their cognate Rho GTPase in a
loading-state-specific manner in situ.
A Protein–Protein Interaction Map for Rho GTPases—To
provide a global overview, we assembled our data into the
first protein–protein interaction network for multiple Rho
GTPases (Fig. 6A). Many proteins were found to interact only
with a single Rho GTPase. However, several proteins such as
Rock2, Arhgef2, and Arhgap5 were surprisingly promiscuous.
For Rock2, promiscuous association with Rac1 and Cdc42
was also validated with the proximity ligation assay (Fig. 5).
The number of shared effectors is probably even higher since
proteins may have escaped detection in individual experi-
ments. Thus, our data indicate extensive crosstalk between
Rho GTPases. Our network also shows that Rac1 and Cdc42
share more interaction partners with each other than with
RhoA, B, C, and D. This is consistent with the higher level of
sequence homology between Rac1 and Cdc42. Intriguingly,
hierarchical clustering of the six Rho GTPases based on our
interaction network results in a dendrogram that resembles
their phylogenetic relationships (Fig. 6B). Hence, closely re-
lated family members share more interaction partners than
distantly related ones. It is tempting to speculate that or-
thologs of some of the shared targets already interacted with
their common ancestor.
DISCUSSION
Rho proteins are key regulators of the actin cytoskeleton



































FIG. 4. Overlap with published interactions. Interactors identified by qGAP (GDP specific interactors in turquoise; GTPS specific
interactors in red) with interactors listed in the HIPPIE protein-protein interaction Database (gray circle). p values indicate significance of the
enrichment of overlapping interactors between qGAP and HIPPIE and are given above each Venn diagram.
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quantitative screen for interaction partners of multiple Rho
GTPases has not yet been published. This is probably mainly
due to the technical challenges involved. For example, while
the yeast two-hybrid approach was used to screen for inter-
action partners of Cdc42 and Rac1 (5), this method cannot
distinguish between the GTP- and the GDP-loaded forms of
the GTPase. Moreover, previous attempts to identify interac-
tors in pull-down assays required huge amounts of input
material (e.g. 14 bovine brains for one experiment) and were
not quantitative (6, 7). Here, we combined the pull-down
assay with SILAC-based or label-free quantification to estab-
lish qGAP as a novel means to identify Rho GTPase interac-
tion partners. We expect that this method is also applicable to
the other 150 proteins of the Ras superfamily. Using qGAP,
we generate the first extensive Rho interaction network in-
cluding the representative family members RhoA, Rac1,
Cdc42, RhoB, RhoC, and RhoD. Our network reveals that
several effectors such as Rock2 bind highly promiscuously.
The network also reflects phylogenetic relationships between
Rho family members. Hence, the specificity of individual
effectors appears to mirror the evolution of Rho GTPase
signaling. Finally, we report many novel Rho GTPase inter-
action partners and thus provide a useful resource for the
community.
Despite the advantages of the qGAP method, it is important
to also keep limitations in mind. First, the method is based on
an in vitro pull-down. It is therefore not clear if identified
interactions also occur in living cells. While 9 out of 11 tested
interactions were validated using the proximity ligation assay
and bacterial toxins (Fig. 5), we cannot provide independent
evidence for all novel interactions. A second limitation is that
we can only detect interactions of proteins that are present in
the lysate used for the pull-down assay. The comparison of
interaction partners identified in HeLa cell lysate and brain
lysate shows that tissue choice is an important factor (Fig. 2).
It should also be noted that differences in experimental design
for some bait proteins might influence our interaction network
(Fig. 6). Finally, qGAP detects both direct and indirect inter-
actions. This can be seen as an advantage or a disadvantage
of the method. In any case, it is important to keep this point in
mind when interpreting the data.
It is also important to note that experiments with HeLa and
brain lysate differ in several ways (choice of tissue, SILAC
versus LFQ, statistical analysis, mass spectrometers used).
This paper does not intend to compare both approaches. The
choice of the biological system and therefore also the method
for quantification will typically depend on the biological ques-
tion of interest: Cell-culture-based systems lend themselves
to SILAC-based quantification while studying in vivo systems
is usually easier with label-free methods. Our results show
that qGAP works with both.
Following up on the biological significance of novel inter-
actors is beyond the scope of this manuscript. However, we
would like to point at a number of interesting observations
that could be addressed in future studies. One remarkable
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FIG. 5. Validation of loading-state-dependent interactions in situ with the proximity ligation assay (PLA). (A) Cells were treated with
CNFY (for RhoA activation) or with CNF1 (Cdc42 and Rac1 activation), fixed, costained with oligonucleotide-coupled antibodies against the Rho
GTPase and interactors. The basal PLA signal (red) increased upon toxin treatment for RhoA-Rock2 (known interaction), Rac1-Rock2 and
Cdc42-IQSEC3 (both novel). (B) Automated quantification shows that toxin treatment significantly increased PLA signals for 9/11 tested novel
interactions.
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associated with the GTPS-bound form of the respective Rho
protein. It is well known that catalytic domains of GEFs pref-
erentially bind to the nucleotide-free form of small GTPases
(43). However, several GEF proteins have been previously
shown to bind to the GTP-bound form of their GTPase via
adjacent domains, like PH (Pleckstrin homolgy domain) do-
mains (44). In fact, all of the above-mentioned GEFs have
been reported to associate with GTP-loaded GTPases (44,
45). Hence, our data corroborate the previously postulated
noncanonical binding mode.
Our data for RhoB, RhoC, and RhoD are particularly inform-
ative since these GTPases are less well characterized. RhoB
and RhoC are closely related to RhoA, yet they have different
effects on cell shape and migration (46). Our interaction data
may therefore help to understand their nonredundant func-
tion. For example, we detect Rhophilin-2 only in the RhoB-
GTPS pull-downs, and this protein was previously shown to
be specific for RhoB (47). Similarly, we also see AKAP13 (the
lymphoid blast crisis oncogene) only in RhoB pull-downs. This
is intriguing since both AKAP13 and RhoB are specifically
involved in apoptosis induction by farnesyl transferase inhib-
itors (48, 49).
In summary, we develop qGAP, to identify interaction part-
ners of Rho GTPases dependent on the loading state. We
present the first extensive screen for Rho GTPase interaction
partners with many new potential binding partners that can be
validated with a high success rate by an orthogonal method.
Our first systematic comparison of Rho GTPase effectors
provides a rich resource for the community that has so far
been lacking.
EXPERIMENTAL PROCEDURES
Experimental Design and Statistical Rationale—For SILAC










































































































































































































FIG. 6. (A) Interaction network between Rho GTPases and identified binding partners of the GTPS-loaded form. Known (gray) and new
(colored) interactions are visualized by line colors and the pie charts for every Rho GTPase. The width of edges corresponds to relative intensity
ratio between GDP- and GTPS-bound Rho GTPase. (B) Clustering Rho GTPases based on shared binding partners mirrors their phylogenetic
relationships.
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HeLa cell culture. Pull-downs were performed with lysate from
one dish (15 cm), and beads from one heavy and one light
experiment were mixed before elution (see Fig. 1). A label
swap experiment was carried out. Label-free experiments
were performed as biological triplicates for each nucleotide
form of a Rho GTPase. This allowed us to do a t test on the
obtained data. Additionally, several tissues were examined (hip-
pocampus, cerebellum, cerebrum, whole brain, see Fig. 2).
Protein Expression and Purification—N-terminal GST-fu-
sion proteins of RhoA, RhoB, RhoC, RhoD, Rac1, and Cdc42
were expressed in E. coli BL21 (DE3) Rosetta. N-terminal
GST-tagged CNF1 and CNFY were expressed in E. coli Tuner
pLysS. Bacteria were grown at 37 °C in TB medium supple-
mented with 100 g/ml ampicillin and 34 g/ml chloramphen-
icol until an OD600 of 0.4. Subsequently, protein expression
was induced by addition of 40 M isopropyl -D-1-thiogalac-
topyranoside and bacteria grown at 18 °C and 180 rpm shak-
ing for at least 15 h. Bacteria were lysed by either passing at
least twice through a microfluidizer or by 6  10 s of sonica-
tion (UP200S, 0.85 amplitude, 0.5 s cycle time, sonotrode
DRH-S2) with cooling steps in between. The lysate was
cleared from debris by centrifugation (50,000 g, 4 °C, 45 min,
JA-12 rotor) and filtered through a 0.2 m pore size filter.
Affinity purification was performed with GSH Sepharose
columns at a flow rate of 1 ml/min. The column was equili-
brated with 6 CV (column volumes) equilibration buffer (20 mM
HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 2.5 mM DTT). The
filtered bacteria lysate was applied, the column was washed
with 30 CV washing buffer (20 mM HEPES, pH 7.5, 300 mM
NaCl, 5 mMMgCl2, 2.5 mM DTT) followed by 5 CV equilibration
buffer and bound proteins were finally eluted with 5 CV elution
buffer (20 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 2.5
mM DTT, 20 mM glutathione). Size exclusion chromatography
was performed for RhoA, Rac1, and Cdc42 with concentrated
protein solutions with a Superdex 200 16/60 column equili-
brated with 2 CV equilibration buffer. The peak fractions con-
taining the protein of interest were pooled and concentrated.
Nucleotide exchange was performed by EDTA-driven
Mg2-depletion as described previously (50). 200 M of the
respective Rho GTPase were incubated with 15 mM EDTA,
150 mM NH4SO4, and 10 mM of GDP or 2 mM GTPS (in 1 M
HEPES, pH 7.5) overnight at 4 °C. The exchange reaction was
stopped by addition of 30 mM MgCl2. Excess nucleotide was
removed by Amicon concentrator or buffer exchange via
FPLC. Determination of bound nucleotide was followed
standard HPLC protocols (51). GST-CNF1 and CNFY were
stored at 20 °C in 50 mM Tris, pH 7.5, 50% glycerol.
GTPase Activity Assays—GTPase activity of RhoA, Cdc42,
and Rac1 was determined by monitoring GTP to GDP ratios
over time by HPLC measurements (52, 53). GTPases were
loaded with GTP prior to measurements. Nucleotide ex-
change of RhoA was performed by EDTA-driven Mg2-deple-
tion (50). Due to the fast intrinsic GTP hydrolysis rates of
Cdc42 and Rac1, nucleotide-free forms of GTPase were gen-
erated prior to GTP loading as described before (53, 54).
For monitoring RhoA activity 50–100 M GTP loaded
GTPase was quickly thawed and diluted in assay buffer (20
mM HEPES, 150 mM NaCl, 5 mM MgCl2, 2.5 mM DTT, pH 7.5)
or prepared cell lysates in a 1:5 ratio. Hydrolysis reaction was
assayed at room temperature and stopped by adding trichlo-
roacetic acid (final concentration of 20%). Samples were cen-
trifuged and neutralized. HPLC measurements were carried
out using a reversed-phase C18 column (Reversed-phase
ODS-2 Hypersil HPLC column, Thermo Scientific) and a pre-
column (Hypersil ODS guard column, Agilent Technologies)
for adsorbing residual denatured protein. Measurements were
carried out in HPLC-buffer containing 10 mM tetrabutylammo-
niumbromide and 100 mM potassium phosphate (pH 6,5) with
7.5% acetonitrile. Nucleotide peaks were detected by meas-
uring adsorption at 254 nm and quantified by integration.
GTPase activity of Cdc42 and Rac1 was monitored as
described (18). Briefly, 50–100 M nucleotide-free GTPase
was quickly mixed with 50 M GTP in GAP buffer (30 mM Tris,
10 mM MgCl2, 3 mM DTT, 10 mM K2HPO4/KH2PO4, pH 7.5).
Subsequently, assay buffer or prepared cell lysate was added
in a 1:5 ratio. Samples were collected as described for RhoA
and subjected to HPLC analysis.
Preparation of Cell Lysates for GTPase Activity Assays—
HEK 293T cells were cultivated at 37 °C with 5% CO2 in
DMEM culture media supplemented with 5% fetal calf serum
(FCS) and 1% penicillin/streptomycin. For GTPase activity
assays lysates of cells transfected with GAP proteins with
a known activity toward the respective GTPase (RhoA:
STARD13, Cdc42: CDGAP; Rac1: ChimerinH206K; all en-
coded as mCitrine fusion proteins on pLP-mCitrine C1 SP
vectors) were used. Transfection was mediated using the
polyethylenimine-mediated DNA transfer method. Cells were
lysed in Nonidet P-40 lysis buffer (1% Nonidet P-40, 10%
glycerol, 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EGTA,
5 mM NaF, Pefabloc, Benzonase), centrifuged, and the super-
natant was washed three times in a VWR 15 ml concentrator
(10 kDa cut-off) with assay buffer. The total protein concen-
tration of the lysate was adjusted to 10 g/l. Lysates were
immediately used in a GAP assay.
Preparation of Mouse Brain Lysate—Mouse brains were
dissected from female BL/6 mice at an age of 12 weeks (kind
gift of Dr. Ibanez-Tallon, MDC Berlin). Brains were either used
as a whole (RhoB, RhoC, RhoD) or separated into a hip-
pocampal (Cdc42), cerebellar (Cdc42, Rac1, RhoA), and re-
maining cerebrum fraction (Cdc42, Rac1, RhoA). The tissue
samples were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4,
150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, and
protease inhibitors (Roche)) by application of 50–100 strokes
in a dounce homogenizer on ice. The lysate was cleared from
debris by two subsequent centrifugation steps at 20,000 g
(4 °C, 20 min) and directly used for experiments. The input for
a single pull-down was 500 g (SILAC), 90 g (hippocampus-
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LFQ), 700 g (cerebellum-LFQ), 1400 g cerebrum-LFQ), and
1500 g (whole-brain-LFQ).
Pull-Down Assays—For pull-down assays cell lysates were
freshly prepared from mouse brains. Experiments were con-
ducted as triplicates, resulting in six single pull-downs per
Rho GTPase (three for the GDP and three for the GTPS-
loaded protein). Each pull-down was analyzed separately by
mass spectrometry and quantified using label-free quantifica-
tion (see below). For SILAC experiments, lysate was prepared
from labeled HeLa cells in adherent culture. The same lysis
buffer as for mice brains was used. Sepharose beads with an
active N-hydroxysuccinimide group were used for covalent
coupling of recombinant proteins (GE Healthcare). 150 l of
bead slurry were used per single pull-down. Storage solution
was removed from bead slurry by centrifugation (1000 g, 2
min). Beads were washed in ice-cold equilibration (1 mM HCl)
buffer and incubated with 500 g of the recombinant protein
for at least 2 h at room temperature. The beads were subse-
quently washed in buffer A (0.5 M ethanolamine, pH 8.3, 0.5 M
NaCl), buffer B (0.1 M sodium acetate, pH 4.0, 0.5 M NaCl) and
incubated in buffer A for 30 min. After wash steps with buffers
B, A, and again B, the cell lysate was added to the beads and
incubation was performed for 30 min at 4 °C. The supernatant
was removed, the beads washed in pull-down wash buffer (50
mM Tris, pH 7.4, 300 mM NaCl, 5 mM MgCl2) twice, and bound
proteins were eluted with 200 l U/T buffer (10 mM HEPES, pH
8.0, 6 M urea, 2 M thiourea) by shaking at 1400 rpm on an
Thermo shaker (Eppendorf) for 15 min. Eluted proteins were
precipitated in 70% ethanol.
Proximity Ligation Assay—HeLa cells were seeded on poly-
L-lysine coated 18-well -slides (ibidi, Martinsried, Germany)
for 1 day in standard cell culture medium (450 cells/well). After
24 h, the medium was replaced by starvation medium (0.2%
FCS) and cells were cultivated for another 24 h. Purified
cytotoxic necrotizing factors (0.4 g/l CNF1-GST or CNFY-GST
in 50 mM Tris, pH 7.5, 50% glycerol) were dissolved in pre-
warmed PBS. Cells were then incubated for 1 h with either
toxin at a final concentration of 0.4 g/ml or the glycerol/PBS
vehicle control. Cells were briefly washed in PBS, fixed with
4% paraformaldehyde and permeabilized with 0.1% Triton
X-100 in PBS. Cells were washed in PBS, and unspecific
binding of antibodies was blocked by incubation in PBS con-
taining 1% BSA, 0.05% Tween20 for 20 min. Reagents for
PLA were obtained from Olink Bioscience (Duolink® in situ
orange starter kit). The primary antibody solution was applied
for 1 h at 37 °C in a humidity chamber. Antibodies were
combinations of one from mouse and one from rabbit donors.
The two PLA probes were mixed, diluted 1:5 in antibody
diluent buffer, and left for 20 min. The primary antibody was
removed from the chamber slide. The slide was washed once;
the PLA probe solution was added and incubated for 1 h at
37 °C. The probes were removed, the slide was washed twice
for 5 min under gentle agitation, and the ligation–ligase solu-
tion was added to each sample and incubated in a preheated
humidity chamber for 30 min at 37 °C. For amplification, the
slide was washed twice for 2 min and the amplification–
polymerase solution was added and incubated for 100 min in
a preheated humidity chamber for 80 min at 37 °C. Finally, the
slides were washed, dried, and In Situ Mounting Medium,
including DAPI was added. Nonspecific signals were as-
sessed by single primary antibody staining. Information about
the antibodies used and their dilution can be found in Sup-
plemental Table 2.
Microscopy and Processing of Images—Images were taken
with a Leica TCS SP5 confocal microscope (Leica Microsys-
tems, Wetzlar, Germany) using a 63x objective and Leica LAS
AF software. Standard parameters were: pinhole of 2.5 AE,
resolution of 2048  2048 pixels, line average of 4. Pictures
were processed with ImageJ (version 1.44, Bethesda, MD)
using the LOCI plugin. Pictures were imported without auto-
scale, threshold was set with a minimum of 30 and a maxi-
mum of 255, and “analyze particle” function was used for
counting of spots.
Sample Preparation and Mass Spectrometry—Protein pel-
lets were redissolved in U/T buffer and subsequently reduced
with dithiothreitol and alkylated with iodoacetamide. Proteins
were digested with LysC and trypsin. The peptides were
desalted off-line and analyzed by online LC-MS on an EASY-
nLC system (Thermo Scientific) coupled to a Q-Exactive-
Orbitrap (Thermo Fisher Scientific, Waltham MA) for cerebrum
and whole-brain samples or an LTQ-Orbitrap-Velos (Thermo
Fisher Scientific) for hippocampus and cerebellum samples.
SILAC samples were analyzed on an LTQ-Orbitrap XL
(Thermo Fisher Scientific) system. 5 l peptide samples were
loaded onto a fritless microcolumn (75 m inner diameter
packed in-house with ReproSil-Pur C18-AQ 3-m resin, Dr.
Maisch GmbH). Peptides were eluted with an 8–60% aceto-
nitrile gradient and 0.5% formic acid. Runs were performed as
4 h gradients at a flow rate of 200 nl/min. Peptides were
ionized at currents of 2.2 kV (Q-Exactive and Orbitrap XL) and
2.3 kV (Orbitrap Velos). The Q-Exactive Orbitrap device was
operated in data-dependent mode with a TOP10 method as
previously described (55). One full scan (m/z range  300 -
1650, r  70,000, target value: 106 ions, maximum injection
time 20 ms) was used to detect precursor ions. The 10 most
intense ions with a charge state greater than1 were selected
for fragmentation (r  17,500, target value  106 ions, isola-
tion window  3 m/z, maximum injection time  60 ms).
Dynamic exclusion time for fragmented precursor ions was
set to 30 s. The Velos Orbitrap was operated in the data-de-
pendent mode with a standard TOP20 method. One full scan
(m/z range  300 - 1700, r  60,000, target value  106 ions)
was used to detect precursor ions. The 20 most intense ions
with a charge state greater than 1 were selected for fragmen-
tation (target value 3000 ions, isolation window  2 m/z).
Dynamic exclusion time for fragmented precursor ions was
set to 60 s.
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The Orbitrap XL operated in data-dependent mode with one
full scan in the Orbitrap analyzer (m/z  300–1700; resolu-
tion  60,000; target value  106 ions). The five most intense
ions with a charge state greater than 1 were selected (target
value  5,000) and fragmented in the linear trap quadrupole
using CID (collision induced dissociation) (35% normalized
collision energy and wideband activation enabled). Dynamic
exclusion for selected precursor ions was 60 s.
Data Analysis and Label-Free Quantification with MaxQuant
and Perseus—MS raw data files were analyzed with the Max-
Quant software package (version 1.3.0.5) that includes the
search engine Andromeda, using default settings (26). Carb-
amidomethylation on cysteines was used as fixed modifica-
tion and oxidation on methionine and acetylated N terminus
as variable modifications. Trypsin was used as protease, in-
cluding cleavage between arginine or lysine and proline.
Missed cleavages were set to two. Peptides were identified
with 6 ppm precursor mass deviation and 20 ppm fragment
mass deviation for Orbitrap Q Exactive devices. Samples from
the LTQ-Orbitrap XL and Velos Orbitrap were allowed to have
up to 6 ppm precursor mass deviation and 0.5 Da fragment
mass deviation. Proteins were searched against the Uniprot
mouse database (version June 2012, 59,377 entries) for LF-
qGAP and Uniprot human database (version June 2012,
86,898 entries) for SILAC-qGAP. Identifications were filtered
to a false discovery rate of 0.01 at the PSM (peptide spectrum
match) and protein level using the target–decoy approach.
The available Requantify option in MaxQuant was enabled.
For label-free quantification, we directly compared peptide
peak intensities between corresponding runs (match between
runs enabled, LFQ min ratio count  2) using the label-free
quantification algorithm (LFQ) implemented in MaxQuant.
Files produced by MaxQuant were further processed using
the Perseus software package (version 1.3.0.4). The “LFQ
Intensity” for each experiment was selected as expression
value. The matrix was filtered for columns “Only identified by
site,” “Contaminant,” and “Reverse hits.” For each set of
experiments, we only accepted proteins that were quantified
in all three replicates of either the GTPS- or GDP-bound
form. The logarithm to the base of 10 was taken from LFQ
intensities and missing values imputed by sampling from a
normal distribution (width 0.3, downshift 1.8). Assuming that
mainly low abundant peaks are the cause for missing data in
shotgun proteomics, the imputation settings aim to simulate
the distribution of low abundant peaks. Missing data were im-
puted in each experiment individually (column per column). The
Gaussian distribution used for imputation was modified by us-
ing 0.3 width (in standard deviation of the real data) and a 1.8
fold downshift (in standard deviation units of the valid data).
The significance of the difference in protein abundance be-
tween the GTPS and GDP pull-downs was calculated with a
two-sided t test. Specific interactors were then selected based
on the combination of the t test p values and the log2 fold
differences as previously described (false discovery rate 5%,
s0  0.5) (56–58). Most interaction partners had at least two
unique peptides. For five potential interactors that were identi-
fied by a single unique peptide, we provide annotated spectra in
Fig. S4 (Cit, Fnbp1l, Pak3, Rps27, Syp). Arhgef7 is listed with
zero unique peptides due to the presence of several splice
variants in the Uniprot database. The interaction network was
plotted using the igraph R-package (59). Enrichment of known
Rho GTPase interactions in identified binding partners was
tested against HIPPIE Database (33) using the hypergeometric
test functions phyper and dhyper from R (version 3.2.2).
The mass spectrometry proteomics data have been depos-
ited to the ProteomeXchange Consortium (http://proteome
central.proteomexchange.org) via the PRIDE partner reposi-
tory with the dataset identifier PXD004190.
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GTPase Nucleotide Tissue Gene names Protein names Protein IDs
Cdc42 GTP Cerebellum 1520402A15Rik;LLeucine rich adapt   A2A8F6;Q9
Cdc42 GTP Cerebrum 1520402A15Rik;LLeucine rich adapt   A2A8F6;Q9
Rac1 GTP Cerebrum 1520402A15Rik;LLeucine rich adapt   A2A8F6;Q9
RhoD GDP Whole Brain 2700060E02Rik UPF0568 protein C  Q4VA29;Q
Rac1 GTP Cerebrum Abi1 Abl interactor 1 B7ZCT9;Q8
Rac1 GTP Cerebellum Abi1 Abl interactor 1 B7ZCT9;Q8
RhoA GTP Cerebrum Abi1 Abl interactor 1 B7ZCT9;Q8
RhoA GTP Cerebellum Abi1 Abl interactor 1 B7ZCT9;Q8
Rac1 GTP Cerebrum Abi2 Abl interactor 2 P62484;Q6
Rac1 GTP Cerebellum Abi2 Abl interactor 2 P62484;Q6
RhoA GTP Cerebrum Abi2 Abl interactor 2 P62484;Q6
RhoA GTP Cerebrum Abr Active breakpoint   Q5SSL4-2;Q
Cdc42 GTP Cerebrum Acadl Long-chain specific   P51174
Cdc42 GTP Hippocampus Acadl Long-chain specific   P51174
Cdc42 GTP Cerebellum Acadl Long-chain specific   P51174
RhoA GTP Cerebrum Acat1 Acetyl-CoA acetylt  Q8QZT1
RhoA GTP Cerebellum Acat1 Acetyl-CoA acetylt  Q8QZT1
RhoB GTP Whole Brain Acat1 Acetyl-CoA acetylt  Q8QZT1
RhoC GTP Whole Brain Acat1 Acetyl-CoA acetylt  Q8QZT1
RhoA GTP Cerebrum Acat2;Acat3 Acetyl-CoA acetylt  Q8CAY6;Q8
Rac1 GTP Cerebrum Adam23 Disintegrin and me    Q5SRA0;Q9
RhoB GTP Whole Brain Akap13 E9Q474;E9
RhoA GTP Cerebellum Anln Actin-binding prote  Q8K298
RhoA GTP Cerebrum Anln Actin-binding prote  Q8K298
Rac1 GDP Cerebellum Arf3;Arf1;Arf2 ADP-ribosylation fa      P61205;P8
Cdc42 GTP Cerebrum Arhgap32 Rho GTPase-activa   Q811P8;Q8
Rac1 GTP Cerebrum Arhgap32 Rho GTPase-activa   Q811P8;Q8
RhoA GTP Cerebrum Arhgap32 Rho GTPase-activa   Q811P8;Q8
RhoC GTP Whole Brain Arhgap32 Rho GTPase-activa   Q811P8;Q8
RhoD GTP Whole Brain Arhgap32 Rho GTPase-activa   Q811P8;Q8
Cdc42 GTP Cerebellum Arhgap5 Rho GTPase-activa   E9PYT0;P9
Rac1 GTP Cerebrum Arhgap5 Rho GTPase-activa   E9PYT0;P9
Rac1 GTP Cerebellum Arhgap5 Rho GTPase-activa   E9PYT0;P9
RhoA GTP Cerebrum Arhgap5 Rho GTPase-activa   E9PYT0;P9
RhoA GTP Cerebellum Arhgap5 Rho GTPase-activa   E9PYT0;P9
RhoB GTP Whole Brain Arhgap5 Rho GTPase-activa   E9PYT0;P9
RhoC GTP Whole Brain Arhgap5 Rho GTPase-activa   E9PYT0;P9
Rac1 GDP Cerebellum Arhgdia Rho GDP-dissociat   Q99PT1
RhoA GDP Cerebellum Arhgdia Rho GDP-dissociat   Q99PT1
RhoA GDP Cerebrum Arhgdia Rho GDP-dissociat   Q99PT1
RhoB GDP Whole Brain Arhgdia Rho GDP-dissociat   Q99PT1
RhoA GTP Cerebrum Arhgef1 Rho guanine nucle    Q61210-5;
RhoA GTP Cerebellum Arhgef1 Rho guanine nucle    Q61210-5;
RhoB GTP Whole Brain Arhgef1 Rho guanine nucle    E9PUF7;Q6
Experiment Interaction Partner
Table legends
Supplemental Table 1: Interaction partners of Rho GTPases. For the six Rho GT                         
identified repeatedly in different tissues.
Cdc42 GTP Cerebrum Arhgef11 Q68FM7;D
Cdc42 GTP Cerebellum Arhgef11 Q68FM7;D
Cdc42 GTP Hippocampus Arhgef11 Q68FM7;D
Rac1 GTP Cerebellum Arhgef11 Q68FM7;D
Rac1 GTP Cerebrum Arhgef11 Q68FM7;D
RhoA GTP Cerebellum Arhgef11 Q68FM7;D
RhoB GTP Whole Brain Arhgef11 Q68FM7;D
RhoC GTP Whole Brain Arhgef11 Q68FM7;D
Cdc42 GTP Cerebrum Arhgef12 Rho guanine nucle    Q8R4H2
Cdc42 GTP Hippocampus Arhgef12 Rho guanine nucle    Q8R4H2
Cdc42 GTP Cerebellum Arhgef12 Rho guanine nucle    Q8R4H2
Rac1 GTP Cerebellum Arhgef12 Rho guanine nucle    Q8R4H2
Rac1 GTP Cerebrum Arhgef12 Rho guanine nucle    Q8R4H2
RhoA GTP Cerebellum Arhgef12 Rho guanine nucle    Q8R4H2
RhoA GDP Cerebellum Arhgef17 Rho guanine nucle    Q80U35;Q
RhoB GDP Whole Brain Arhgef17 Rho guanine nucle    Q80U35-2;
RhoC GDP Whole Brain Arhgef17 Rho guanine nucle    Q80U35-2;
RhoA GTP Cerebellum Arhgef18 Rho guanine nucle    Q6P9R4;Q6
RhoA GTP Cerebrum Arhgef18 Rho guanine nucle    Q6P9R4;Q6
RhoB GTP Whole Brain Arhgef18 Rho guanine nucle    Q6P9R4;Q6
Cdc42 GTP Cerebrum Arhgef2 Rho guanine nucle    Q60875;H3
Rac1 GTP Cerebrum Arhgef2 Rho guanine nucle    Q60875;H3
RhoA GTP Cerebrum Arhgef2 Rho guanine nucle    Q60875;H3
RhoA GTP Cerebellum Arhgef2 Rho guanine nucle    Q60875;H3
RhoB GTP Whole Brain Arhgef2 Rho guanine nucle    Q60875;H3
RhoC GTP Whole Brain Arhgef2 Rho guanine nucle    Q60875;H3
RhoD GTP Whole Brain Arhgef2 Rho guanine nucle    Q60875;H3
Cdc42 GTP Cerebrum Arhgef6 Rho guanine nucle    F6WMJ3;Q
Cdc42 GTP Cerebellum Arhgef6 Rho guanine nucle    F6WMJ3;Q
Cdc42 GTP Hippocampus Arhgef6 Rho guanine nucle    F6WMJ3;Q
Rac1 GTP Cerebellum Arhgef6 Rho guanine nucle    F6WMJ3;Q
Rac1 GTP Cerebrum Arhgef6 Rho guanine nucle    F6WMJ3;Q
Cdc42 GTP Cerebrum Arhgef7 Rho guanine nucle    Q9ES28;Q9
Cdc42 GTP Hippocampus Arhgef7 Rho guanine nucle    Q9ES28;Q9
Cdc42 GTP Cerebellum Arhgef7 Rho guanine nucle    Q9ES28;Q9
Rac1 GTP Cerebrum Arhgef7 Rho guanine nucle    Q9ES28;Q9
Rac1 GTP Cerebellum Arhgef7 Rho guanine nucle    Q9ES28;Q9
RhoA GTP Cerebrum Arhgef7 Rho guanine nucle    Q9ES28;Q9
RhoC GDP Whole Brain Arl2 ADP-ribosylation fa   Q9D0J4
RhoA GTP Cerebrum Ass1 Argininosuccinate P16460;Q3
Cdc42 GTP Cerebrum Atl1 Atlastin-1 Q8BH66
RhoA GDP Cerebellum Atp5d ATP synthase subu   Q4FK74;Q9
RhoD GDP Whole Brain Atp6v1f V-type proton ATP   Q9D1K2;F7
RhoD GDP Whole Brain Baiap2 Brain-specific angio     B1AZ47;Q8
Cdc42 GTP Cerebrum Baiap2 B1AZ45;Q8
Cdc42 GTP Cerebrum Baiap2 Brain-specific angio     Q3UKP6;Q
Cdc42 GTP Cerebellum Baiap2 Brain-specific angio     Q3UKP6;Q
Cdc42 GTP Hippocampus Baiap2 Brain-specific angio     Q3UKP6;Q
Rac1 GTP Cerebrum Bckdk [3-methyl-2-oxobu     O55028;Q3
Rac1 GTP Cerebellum Brk1 Protein BRICK1 Q91VR8
Rac1 GTP Cerebrum Brk1 Protein BRICK1 Q91VR8
RhoA GTP Cerebrum Brk1 Protein BRICK1 Q91VR8
RhoC GTP Whole Brain Cadm3 Cell adhesion mole  Q99N28;E9
Cdc42 GTP Cerebellum Camk2b Calcium/calmoduli       Q5SVJ0;P2
RhoA GTP Cerebrum Capza1 F-actin-capping pro   E9PWZ5;P4
RhoA GTP Cerebrum Ccdc6 Coiled-coil domain   D3YZP9
RhoB GDP Whole Brain Cdc42 Cell division contro    P60766;Q3
Cdc42 GTP Cerebrum Cdc42bpa Serine/threonine-p    E9PVY0;D3
Cdc42 GTP Hippocampus Cdc42bpa Serine/threonine-p    E9PVY0;D3
Cdc42 GTP Cerebellum Cdc42bpa Serine/threonine-p    E9PVY0;D3
Rac1 GTP Cerebrum Cdc42bpa Serine/threonine-p    E9PVY0;D3
Cdc42 GTP Cerebrum Cdc42bpb Serine/threonine-p    Q7TT50;P5
Cdc42 GTP Hippocampus Cdc42bpb Serine/threonine-p    Q7TT50;P5
Cdc42 GTP Cerebellum Cdc42bpb Serine/threonine-p    Q7TT50;P5
Rac1 GTP Cerebellum Cdc42bpb Serine/threonine-p    Q7TT50;P5
Rac1 GTP Cerebrum Cdc42bpb Serine/threonine-p    Q7TT50;P5
Cdc42 GTP Cerebellum Cdc42ep1 Cdc42 effector pro  Q91W92
Rac1 GTP Cerebellum Cdc42ep1 Cdc42 effector pro  Q91W92
Cdc42 GTP Cerebellum Cdc42ep4 Cdc42 effector pro  A2A6Q1;Q
Rac1 GTP Cerebellum Cdc42ep4 Cdc42 effector pro  A2A6Q1;Q
Rac1 GTP Cerebrum Cdc42ep4 Cdc42 effector pro  A2A6Q1;Q
Rac1 GTP Cerebrum Cdc42se2 CDC42 small effect   Q8BGH7
Rac1 GTP Cerebrum Cit Citron Rho-interac  E9QL53;P4
RhoA GTP Cerebellum Cit Citron Rho-interac  E9QL53;P4
RhoA GTP Cerebrum Cit Citron Rho-interac  E9QL53;P4
RhoB GTP Whole Brain Cit Citron Rho-interac  E9QPY8;P4
RhoC GTP Whole Brain Cit Citron Rho-interac  E9QPY8;P4
Rac1 GTP Cerebrum Cryzl1 Quinone oxidoredu   Q921W4;D
RhoB GDP Whole Brain Ctnnd1 Catenin delta-1 E9Q8Z8;E9
Rac1 GTP Cerebrum Cyfip2 Cytoplasmic FMR1   Q5SQX6;E9
Rac1 GTP Cerebellum Cyfip2 Cytoplasmic FMR1   Q5SQX6;E9
RhoA GTP Cerebrum Cyfip2 Cytoplasmic FMR1   Q5SQX6;E9
RhoB GTP Whole Brain Daam1 Disheveled-associa     Q8BPM0;Q
RhoC GTP Whole Brain Daam1 Disheveled-associa     Q8BPM0;Q
RhoB GTP Whole Brain Daam2 Disheveled-associa     Q80U19;Q
RhoC GTP Whole Brain Daam2 Disheveled-associa     Q80U19;Q
RhoD GTP Whole Brain Daam2 Disheveled-associa     Q80U19;Q
RhoD GTP Whole Brain Diap1;Diaph1 Protein diaphanou   E9PV41;E9
Cdc42 GTP Cerebellum Diap2;Diaph2 Protein diaphanou   E9Q4U7;Q
Cdc42 GTP Cerebrum Diap2;Diaph2 Protein diaphanou   E9Q4U7;Q
RhoB GDP Whole Brain Diras2 GTP-binding prote  Q3UWU7;Q
Cdc42 GTP Hippocampus Dock9 E9QMR2
Rac1 GTP Cerebellum Dock9 E9QMR2
Rac1 GTP Cerebrum Dock9 E9QMR2
Cdc42 GTP Cerebrum Dync1i2 Cytoplasmic dynei     A2BFF9;Q3
Cdc42 GTP Cerebellum Dynll2 Dynein light chain  B2KGQ2;Q
Rac1 GTP Cerebellum Dynll2 Dynein light chain  B2KGQ2;Q
RhoB GTP Whole Brain Ech1 Delta(3,5)-Delta(2,   O35459;F7
Rac1 GTP Cerebellum Echdc1 Ethylmalonyl-CoA Q9D9V3;Q
Rac1 GTP Cerebrum Echdc1 Ethylmalonyl-CoA Q9D9V3;Q
RhoB GDP Whole Brain Eef1a2 Elongation factor 1    P62631;B7
RhoC GDP Whole Brain Eef1a2 Elongation factor 1    P62631;B7
RhoD GDP Whole Brain Eef1a2 Elongation factor 1    P62631;B7
Cdc42 GDP Cerebrum Eif5a;Eif5a2 Eukaryotic translat        P63242;Q8
Rac1 GTP Cerebrum Elmo1 Engulfment and ce    F8WIL9;Q8
Rac1 GTP Cerebrum Elmo2 Engulfment and ce    Q8BHL5-2;
Rac1 GTP Cerebellum Elmo2 Engulfment and ce    Q8BHL5-2;
Cdc42 GDP Cerebrum Eps15l1 Epidermal growth     Q60902;F8
RhoB GTP Whole Brain Exoc3 Exocyst complex co  Q6KAR6;Q
RhoB GDP Whole Brain Fahd1 Acylpyruvase FAHD  Q3UQY4;Q
RhoA GTP Cerebrum Fam65a Protein FAM65A G5E8A2;Q6
RhoA GTP Cerebellum Fam65a Protein FAM65A G5E8A2;Q6
RhoB GTP Whole Brain Fam65a Protein FAM65A G5E8A2;Q6
RhoC GTP Whole Brain Fam65a Protein FAM65A G5E8A2;Q6
RhoB GTP Whole Brain Fam65b Protein FAM65B Q80U16
Cdc42 GTP Cerebrum Fam89b Q9QUI1;Q7
RhoA GTP Cerebellum Fh Fumarate hydratas  P97807;P9
RhoD GDP Whole Brain Fkbp2 Peptidyl-prolyl cis-     P45878;Q3
Cdc42 GTP Hippocampus Fnbp1 Formin-binding pro  Q80TY0;A2
Cdc42 GTP Cerebrum Fnbp1 Formin-binding pro  Q80TY0;A2
Cdc42 GTP Cerebellum Fnbp1 Formin-binding pro  Q80TY0;A2
Rac1 GTP Cerebellum Fnbp1 Formin-binding pro  Q80TY0;A2
Cdc42 GTP Hippocampus Fnbp1l E9PUK3
Cdc42 GTP Cerebellum Fnbp1l E9PUK3
Cdc42 GTP Cerebrum Fnbp1l E9PUK3
RhoD GDP Whole Brain Gabbr1 Gamma-aminobut       Q9WV18;Q
Cdc42 GDP Cerebrum Gad2 Glutamate decarbo  P48320;Q5
RhoA GDP Cerebrum Gart Trifunctional purin       Q64737;Q3
RhoB GTP Whole Brain Gdap1 Ganglioside-induce    O88741;O8
Cdc42 GTP Cerebrum Git1 ARF GTPase-activa   Q68FF6
Cdc42 GTP Hippocampus Git1 ARF GTPase-activa   Q68FF6
Cdc42 GTP Cerebellum Git1 ARF GTPase-activa   Q68FF6
Rac1 GTP Cerebrum Git1 ARF GTPase-activa   Q68FF6
Rac1 GTP Cerebellum Git1 ARF GTPase-activa   Q68FF6
Cdc42 GTP Cerebrum Git2 E9PVA6;Q8
Cdc42 GTP Cerebellum Git2 E9PVA6;Q8
Rac1 GTP Cerebrum Git2 E9PVA6;Q8
Rac1 GTP Cerebellum Git2 E9PVA6;Q8
RhoB GTP Whole Brain Gnao1 Guanine nucleotid     P18872;Q5
RhoC GTP Whole Brain Gpm6b Neuronal membra   A2AEG6;P3
RhoB GDP Whole Brain Gpn1 GPN-loop GTPase Q4VAB2;Q
Cdc42 GTP Cerebrum Grb2 Growth factor rece   Q3U5I5;Q6
RhoA GTP Cerebrum Grlf1;Arhgap35 Rho GTPase-activa   B2RTN5;Q9
RhoB GTP Whole Brain Gsn Gelsolin A2AL35;P1
RhoB GDP Whole Brain Gtpbp10 GTP-binding prote  Q8K013;F8
RhoC GTP Whole Brain Gucy1a2 F8VQK3;F6
RhoD GTP Whole Brain Hexdc Hexosaminidase D Q3U4H6-2
Cdc42 GTP Cerebellum Homer3 Homer protein hom  Q99JP6-2;Q
Rac1 GTP Cerebellum Homer3 Homer protein hom  Q99JP6-2;Q
RhoA GTP Cerebellum Homer3 Homer protein hom  Q99JP6-2;Q
Cdc42 GDP Cerebellum Hspe1 10 kDa heat shock  Q4KL76;Q6
Cdc42 GDP Cerebellum Igsf5;Pcp4 Purkinje cell prote  D3YXH0;P6
RhoB GTP Whole Brain Igtp Q9DCE9;E9
Rac1 GTP Cerebrum Inppl1 Phosphatidylinosit    Q6P549
RhoA GTP Cerebellum Inppl1 Phosphatidylinosit    Q6P549
RhoA GTP Cerebrum Inppl1 Phosphatidylinosit    Q6P549
RhoB GTP Whole Brain Inppl1 Phosphatidylinosit    Q6P549
RhoC GTP Whole Brain Inppl1 Phosphatidylinosit    Q6P549
RhoA GTP Cerebrum Iqsec2 IQ motif and SEC7   E9QAD8;A4
Cdc42 GTP Cerebrum Iqsec3 IQ motif and SEC7   Q3TES0;D6
Rac1 GTP Cerebellum Iqsec3 IQ motif and SEC7   Q3TES0;D6
Rac1 GTP Cerebrum Iqsec3 IQ motif and SEC7   Q3TES0;D6
RhoA GTP Cerebrum Iqsec3 IQ motif and SEC7   Q3TES0;D6
Cdc42 GDP Cerebrum Isca2 Iron-sulfur cluster    Q9DCB8
Rac1 GDP Cerebrum Kalrn Kalirin A2CG49-7;
Cdc42 GDP Cerebrum Kcnab2 Voltage-gated pota    E0CXZ9;P6
RhoA GTP Cerebrum Kif2a Kinesin-like protein E0CZ72;P2
RhoB GDP Whole Brain Lgalsla Galectin-related pr  Q8VED9
Rac1 GTP Cerebellum Lin7a Protein lin-7 homo  Q8JZS0;Q3
Cdc42 GTP Cerebrum Llgl1 Lethal(2) giant larv    Q80Y17
Cdc42 GTP Cerebellum Llgl1 Lethal(2) giant larv    Q80Y17
RhoB GTP Whole Brain Lrpap1 Alpha-2-macroglob   F6SY09;P55
RhoB GTP Whole Brain Lrrc47 Leucine-rich repea   E9PV22;B1
Cdc42 GTP Cerebrum Lurap1l Leucine rich adapt   Q8K2P1
Cdc42 GDP Cerebrum Lypla2 Acyl-protein thioes  B1AV56;Q9
RhoD GDP Whole Brain Map4;Mtap4 Microtubule-assoc    P27546;P2
RhoA GDP Cerebrum Mat2b Methionine adeno    Q99LB6;Q9
RhoA GDP Cerebrum Mccc1 Methylcrotonoyl-C     Q99MR8;F
RhoD GTP Whole Brain Mettl21d Methyltransferase   Q8C436;Q8
RhoB GTP Whole Brain Mpdz Multiple PDZ doma  F8WGE8;Q
RhoD GDP Whole Brain Mpi Mannose-6-phosp  Q3V100;Q9
Rac1 GDP Cerebrum Mpp1 55 kDa erythrocyte  P70290;Q5
RhoD GTP Whole Brain Mtap4 Microtubule-assoc  F6XPV7;F6
Cdc42 GTP Cerebrum Myl6;Gm8894 Myosin light polyp  Q60605;Q6
Cdc42 GTP Cerebrum Mzt2 Mitotic-spindle org   Q9CQ25
Rac1 GTP Cerebrum Mzt2 Mitotic-spindle org   Q9CQ25
Cdc42 GDP Cerebrum Ncald Neurocalcin-delta Q91X97;D3
RhoA GDP Cerebrum Nceh1 Neutral cholestero    Q8BLF1
RhoB GTP Whole Brain Nceh1 Neutral cholestero    Q8BLF1;Q8
Rac1 GTP Cerebrum Nckap1 Nck-associated pro  A2AS98;A2
Rac1 GTP Cerebellum Nckap1 Nck-associated pro  A2AS98;A2
RhoA GDP Cerebrum Ndufa4 NADH dehydrogen       Q62425
RhoA GDP Cerebrum Ndufa8 NADH dehydrogen       Q9DCJ5
RhoC GTP Whole Brain Ndufs2 NADH dehydrogen      Q91WD5;D
RhoA GTP Cerebrum Nefh Neurofilament hea  P19246;F7
RhoB GDP Whole Brain Nudt16 U8 snoRNA-decapp  Q6P3D0;Q
RhoC GDP Whole Brain Nudt16 U8 snoRNA-decapp  Q6P3D0;Q
RhoD GDP Whole Brain Nudt16 U8 snoRNA-decapp  Q6P3D0;Q
Cdc42 GTP Cerebrum Opa1 Dynamin-like 120 k        P58281-2;P
Cdc42 GTP Cerebellum Opa1 Dynamin-like 120 k        P58281-2;P
Cdc42 GTP Hippocampus Opa1 Dynamin-like 120 k        P58281-2;P
Rac1 GTP Cerebrum Opa1 Dynamin-like 120 k        P58281-2;P
Rac1 GTP Cerebellum Opa1 Dynamin-like 120 k        P58281-2;P
Rac1 GDP Cerebrum Pacsin2 Protein kinase C an        Q3TDA7;Q
Rac1 GDP Cerebellum Pacsin2 Protein kinase C an        Q3TDA7;Q
Cdc42 GTP Cerebrum Pak1 Serine/threonine-p    G5E884;O8
Cdc42 GTP Hippocampus Pak1 Serine/threonine-p    G5E884;O8
Cdc42 GTP Cerebellum Pak1 Serine/threonine-p    G5E884;O8
Rac1 GTP Cerebrum Pak1 Serine/threonine-p    G5E884;O8
Rac1 GTP Cerebellum Pak1 Serine/threonine-p    G5E884;O8
Cdc42 GTP Cerebrum Pak2 Serine/threonine-p    Q8CIN4
Cdc42 GTP Cerebellum Pak2 Serine/threonine-p    Q8CIN4
Cdc42 GTP Hippocampus Pak2 Serine/threonine-p    Q8CIN4
Rac1 GTP Cerebrum Pak2 Serine/threonine-p    Q8CIN4
Cdc42 GTP Hippocampus Pak3 A3KGC1;Q6
Cdc42 GTP Cerebrum Pak3 A3KGC1;Q6
Cdc42 GTP Cerebellum Pak3 A3KGC1;Q6
Rac1 GTP Cerebrum Pak3 A3KGC1;Q6
Rac1 GTP Cerebellum Pak3 A3KGC1;Q6
Cdc42 GTP Cerebellum Pak4 Serine/threonine-p    Q8BTW9
Rac1 GTP Cerebrum Pak6 Serine/threonine-p    Q3ULB5
Cdc42 GTP Cerebrum Pak7 Serine/threonine-p    B1AYC2;Q8
Cdc42 GTP Cerebellum Pard6a Partitioning defect    Q9Z101;D3
Rac1 GTP Cerebrum Pard6a Partitioning defect    Q9Z101;D3
Rac1 GTP Cerebrum Pddc1 Parkinson disease    Q8BFQ8
RhoB GDP Whole Brain Pde6d Retinal rod rhodop      O55057;Q3
RhoB GTP Whole Brain Pi4ka E9Q3L2;F6
Cdc42 GTP Cerebrum Pik3cb Phosphatidylinosit       Q8BTI9
Cdc42 GTP Cerebellum Pik3r1 Phosphatidylinosit     P26450;Q8
Cdc42 GTP Cerebrum Pik3r1 Phosphatidylinosit     P26450;Q8
Rac1 GTP Cerebellum Pik3r1 Phosphatidylinosit     P26450;Q8
Rac1 GTP Cerebrum Pik3r1 Phosphatidylinosit     P26450;Q8
Rac1 GTP Cerebrum Pip4k2b Phosphatidylinosit     Q3UJ95;Q8
RhoA GTP Cerebrum Pkn1 Serine/threonine-p   P70268-2;P
RhoB GTP Whole Brain Pkn1 Serine/threonine-p   P70268-2;P
RhoD GTP Whole Brain Pkn1 Serine/threonine-p   P70268-2;P
RhoB GTP Whole Brain Plcxd3 PI-PLC X domain-co   G3X9A7;Q8
Cdc42 GDP Cerebrum Pld3 Phospholipase D3 O35405
RhoA GTP Cerebrum Plekhg5 Pleckstrin homolog      Q66T02;B1
RhoB GTP Whole Brain Plekhg5 Pleckstrin homolog      Q66T02;B1
RhoD GTP Whole Brain Plekhg5 Pleckstrin homolog      Q66T02;B1
Rac1 GTP Cerebrum Plxnb1 Plexin-B1 Q8CJH3
RhoD GTP Whole Brain Plxnb2 Plexin-B2 B2RXS4;E9
RhoC GTP Whole Brain Pnpo Pyridoxine-5-phos  Q91XF0;A2
Cdc42 GTP Cerebellum Ppm1h Protein phosphata  Q3UYC0;Q
Cdc42 GTP Cerebellum Ppp1ca Serine/threonine-p      P62137;Q3
Rac1 GTP Cerebellum Ppp1r21 Protein phosphata     Q3TDD9;Q
Rac1 GTP Cerebrum Ppp1r21 Protein phosphata     Q3TDD9;Q
RhoC GTP Whole Brain Ppp2r5c Serine/threonine-p         Q60996;Q6
Cdc42 GDP Cerebrum Prex1 Phosphatidylinosit      Q69ZK0
Cdc42 GTP Cerebrum Prkci Protein kinase C io  Q5DTK3;Q
Cdc42 GTP Cerebellum Prkci Protein kinase C io  Q5DTK3;Q
RhoB GTP Whole Brain Prrt3 Proline-rich transm   Q6PE13
RhoB GTP Whole Brain Psd3 PH and SEC7 doma   Q8C0E9;E9
Cdc42 GDP Cerebrum Psma6 Proteasome subun   Q9QUM9;E
Rac1 GTP Cerebrum Psmd9 26S proteasome n    Q9CR00
RhoB GTP Whole Brain Psme2 Proteasome activa    P97372;Q5
RhoB GDP Whole Brain Ran GTP-binding nuclea   P62827;A6
RhoC GDP Whole Brain Ran GTP-binding nuclea   P62827;A6
RhoD GDP Whole Brain Ran GTP-binding nuclea   P62827;A6
RhoC GTP Whole Brain Rap1b;Rap1a Ras-related protein   Q52L50;Q9
RhoC GDP Whole Brain Rap1gds1 E9Q912;E9
Cdc42 GTP Cerebrum Raph1 F2Z408;G5
RhoD GTP Whole Brain Rbfox1 RNA binding prote    Q9JJ43-3;Q
Cdc42 GTP Hippocampus Rgs14 Regulator of G-pro   P97492
Cdc42 GTP Cerebrum Rgs14 Regulator of G-pro   P97492
Rac1 GTP Cerebrum Rgs14 Regulator of G-pro   P97492
RhoB GTP Whole Brain Rhpn2 Rhophilin-2 Q8BWR8
RhoB GTP Whole Brain Rock1 Rho-associated pro   P70335;P7
Cdc42 GTP Cerebrum Rock2 Rho-associated pro   F8VPK5;P7
Rac1 GTP Cerebrum Rock2 Rho-associated pro   F8VPK5;P7
RhoA GTP Cerebellum Rock2 Rho-associated pro   F8VPK5;P7
RhoA GTP Cerebrum Rock2 Rho-associated pro   F8VPK5;P7
RhoB GTP Whole Brain Rock2 Rho-associated pro   E9PYM9;F8
RhoC GTP Whole Brain Rock2 Rho-associated pro   E9PYM9;F8
RhoD GDP Whole Brain Rpl22 60S ribosomal prot  P67984;Q4
RhoA GDP Cerebellum Rps27;Gm17241 40S ribosomal prot  Q6ZWU9;E
RhoA GTP Cerebellum Rtkn Rhotekin Q8C6B2-2;
RhoA GTP Cerebrum Rtkn Rhotekin Q8C6B2-2;
RhoB GTP Whole Brain Rtkn Rhotekin Q8C6B2;Q8
RhoB GTP Whole Brain Scamp3 Secretory carrier-a    Q3UXS0;O3
Rac1 GTP Cerebrum Sccpdh Saccharopine dehy  Q8R127;D3
Cdc42 GTP Cerebellum Sept4 Septin-4 P28661;P2
Cdc42 GTP Cerebellum Sept7 Septin-7 E9Q9F5;O5
Cdc42 GTP Cerebellum Sept8 Septin-8 B1AQZ0;B1
Cdc42 GTP Cerebellum Sestd1 SEC14 domain and    Q80UK0
Cdc42 GTP Cerebrum Sestd1 SEC14 domain and    Q80UK0
Rac1 GTP Cerebrum Sestd1 SEC14 domain and    Q80UK0
Rac1 GTP Cerebrum Sh3rf1 E3 ubiquitin-prote   Q69ZI1;E9Q
RhoA GDP Cerebellum Slc25a18 Mitochondrial glut   Q9DB41;Q
RhoA GTP Cerebrum Slk STE20-like serine/t  O54988;A2
Cdc42 GTP Cerebellum Snap91 Clathrin coat assem   Q61548;Q6
RhoC GTP Whole Brain Snx27 Sorting nexin-27 Q3UHD6;Q
Cdc42 GTP Cerebellum Sowahc Ankyrin repeat dom   Q8C0J6
Cdc42 GTP Cerebrum Sowahc Ankyrin repeat dom   Q8C0J6
Rac1 GTP Cerebrum Srgap3 SLIT-ROBO Rho GT   F8VPQ4;Q8
RhoB GDP Whole Brain Srp54;Srp54c Signal recognition    P14576;E9
RhoA GTP Cerebrum St13 Hsc70-interacting Q99L47;F8
Rac1 GDP Cerebrum Stam Signal transducing   P70297;Q3
RhoB GTP Whole Brain Stx16 Syntaxin-16 E9QM25;Q
RhoA GTP Cerebrum Sult4a1 Sulfotransferase 4AP63046;P6
RhoA GDP Cerebellum Syp F8WGK2
Cdc42 GTP Cerebellum Taok2 Serine/threonine-p   Q6ZQ29-2;
Cdc42 GTP Cerebrum Taok2 Serine/threonine-p   Q6ZQ29-2;
Rac1 GDP Cerebrum Tiam2 T-lymphoma invas     Q6ZPF3;Q6
Rac1 GDP Cerebellum Traf7 E3 ubiquitin-prote   F8WJF7;Q8
Rac1 GTP Cerebrum Trim3 Tripartite motif-co   Q9R1R2;Q3
Rac1 GTP Cerebellum Trim3 Tripartite motif-co   Q9R1R2;Q3
Rac1 GDP Cerebrum Trio Triple functional do  Q0KL02-4;Q
Cdc42 GTP Hippocampus Trip10 Cdc42-interacting  Q8CJ53;Q8
Cdc42 GTP Cerebellum Trip10 Cdc42-interacting  Q8CJ53;Q8
Cdc42 GTP Cerebrum Trip10 Cdc42-interacting  Q8CJ53;Q8
RhoC GTP Whole Brain Tsn Translin Q545E6;Q6
RhoB GTP Whole Brain Tsnax Translin-associated  Q9QZE7
RhoD GDP Whole Brain Ufc1 Ubiquitin-fold mod   Q9CR09
Rac1 GTP Cerebrum Wasf1 Wiskott-Aldrich sy     Q8R5H6;B1
Rac1 GTP Cerebellum Wasf1 Wiskott-Aldrich sy     Q8R5H6;B1
RhoA GTP Cerebrum Wasf1 Wiskott-Aldrich sy     Q8R5H6;B1
Rac1 GTP Cerebrum Wasf3 Wiskott-Aldrich sy     Q8VHI6;D3
Rac1 GTP Cerebellum Wasf3 Wiskott-Aldrich sy     Q8VHI6;D3
RhoA GTP Cerebrum Wasf3 Wiskott-Aldrich sy     Q8VHI6;D3
Cdc42 GTP Cerebrum Wasl Neural Wiskott-Ald   Q3TXX8;Q9
Cdc42 GTP Cerebellum Wasl Neural Wiskott-Ald   Q3TXX8;Q9
Cdc42 GTP Hippocampus Wasl Neural Wiskott-Ald   Q3TXX8;Q9
RhoA GDP Cerebrum Wbp2 WW domain-bindi   E9Q1S7;P9
Cdc42 GTP Cerebrum Wipf1 WAS/WASL-interac     A2ATB9;Q8
Cdc42 GTP Cerebellum Wipf2 WAS/WASL-interac     Q6PEV3;D3
Cdc42 GTP Cerebrum Wipf2 WAS/WASL-interac     Q6PEV3;D3
Cdc42 GTP Hippocampus Wipf2 WAS/WASL-interac     Q6PEV3;D3
Cdc42 GTP Cerebrum Wipf3 WAS/WASL-interac     P0C7L0;E9
Cdc42 GTP Hippocampus Wipf3 WAS/WASL-interac     P0C7L0;E9
Cdc42 GTP Cerebellum Wipf3 WAS/WASL-interac     P0C7L0;E9
Cdc42 GTP Cerebrum Uncharacterized p   Q8C3W1
RhoB GTP Whole Brain Q80U16-5;
RhoB GTP Whole Brain Uncharacterized p   Q8C3W1
RhoC GTP Whole Brain Uncharacterized p   Q8C3W1
RhoD GTP Whole Brain Uncharacterized p   Q8C3W1
Majority pr  LFQ intens LFQ intens  LFQ intens  LFQ intens  LFQ intens  LFQ intens  Peptides Razor + un  
A2A8F6;Q9 26,7144 24,8568 24,3541 27,7072 29,0261 27,6589 9 9
A2A8F6;Q9 26,103 24,001 24,1774 28,114 28,7797 29,1471 9 9
A2A8F6;Q9 24,0402 23,955 23,3534 26,3918 26,3188 26,1309 9 9
Q4VA29;Q 24,2248 23,8377 25,0461 21,5993 21,9763 22,6614 8 8
B7ZCT9;Q8 29,4318 28,9221 29,4554 33,0053 33,7752 33,4501 20 20
B7ZCT9;Q8 27,1735 27,0548 26,2609 33,0809 32,9178 32,6433 20 20
B7ZCT9;Q8 28,9457 29,6813 29,2684 30,6671 30,7975 31,027 20 20
B7ZCT9;Q8 27,4278 27,184 25,7252 28,7182 29,7158 29,5531 20 20
P62484;Q6 27,7149 27,5261 27,3545 32,3513 32,9999 32,7189 19 14
P62484;Q6 24,0128 24,6245 25,4851 31,0749 31,4696 30,769 19 14
P62484;Q6 26,8876 27,2019 27,9978 28,9739 30,027 29,9408 19 14
Q5SSL4-2;Q 25,7241 24,328 23,6758 27,1176 26,3712 26,6047 10 10
P51174 28,2785 27,4064 27,5851 30,9035 31,2396 31,2904 16 16
P51174 26,2354 26,1121 26,6682 29,4417 29,8698 30,0161 16 16
P51174 28,3998 27,5064 27,6793 31,7403 32,1335 31,9478 16 16
Q8QZT1 32,4212 31,9864 32,2419 36,2045 36,5458 36,3435 32 32
Q8QZT1 31,4219 31,1635 31,2171 36,9963 37,6617 37,0694 32 32
Q8QZT1 28,5669 28,7721 28,5608 30,8271 30,5858 30,1503 24 24
Q8QZT1 28,8845 28,5187 28,923 31,223 30,7321 30,7663 24 24
Q8CAY6;Q8 24,4378 24,9038 24,3826 26,9768 27,0752 27,119 6 6
Q5SRA0;Q9 23,8806 24,4027 24,3418 26,7967 26,6786 27,0385 5 5
E9Q474;E9 21,7996 23,6361 21,2988 24,8006 25,4305 26,021 12 12
Q8K298 26,0585 26,3797 25,6635 27,2602 28,6342 28,3776 11 11
Q8K298 23,6278 25,5042 23,9479 26,0371 27,7595 28,4481 11 11
P61205;P8 30,1326 28,8862 29,5733 27,3634 26,5539 27,7687 10 10
Q811P8;Q8 26,7367 26,7167 24,0727 31,4999 30,9978 31,3584 28 28
Q811P8;Q8 24,2684 23,54 24,5196 29,6697 30,2397 29,7885 28 28
Q811P8;Q8 24,1841 24,34 24,7877 28,3694 28,6 28,5205 28 28
Q811P8;Q8 22,7986 23,851 23,8435 26,228 25,9613 26,5869 31 31
Q811P8;Q8 25,2048 24,4963 23,949 28,3637 27,6138 28,8439 31 31
E9PYT0;P9 25,7505 25,4051 24,6669 27,1046 27,275 27,5442 48 48
E9PYT0;P9 23,8042 25,6346 27,9559 30,5384 30,9817 30,9041 48 48
E9PYT0;P9 24,9483 25,9081 25,0086 31,8133 32,1457 31,9672 48 48
E9PYT0;P9 26,443 23,1835 25,9507 30,0878 30,7069 31,0829 48 48
E9PYT0;P9 26,4408 25,7397 25,5039 30,8284 32,0866 32,0247 48 48
E9PYT0;P9 23,6065 23,179 23,9389 25,6518 25,9859 26,3764 23 23
E9PYT0;P9 22,7425 23,1175 24,1878 26,0187 25,4909 26,1927 23 23
Q99PT1 29,6284 29,6673 29,5755 28,0182 27,3527 27,6115 13 13
Q99PT1 31,1526 31,4984 32,3304 27,2925 25,4624 28,9325 13 13
Q99PT1 31,7337 31,6256 32,3336 30,0288 29,589 29,4944 13 13
Q99PT1 29,5408 29,6502 29,1115 28,4462 28,4161 27,9086 14 14
Q61210-5; 22,7258 28,2202 28,1739 30,0104 31,6156 31,3287 33 33
Q61210-5; 24,0586 24,232 24,4934 28,8167 30,8581 31,1701 33 33
E9PUF7;Q6 28,1501 28,1497 28,2229 29,9924 30,3526 30,3907 49 49
 Results mass spectr
 
            Pases RhoA, RhoB, RhoC, RhoD, Rac1 and Cdc42 a total number of 293 distinct i           
    
Q68FM7 27,6711 28,257 28,0774 32,6095 32,8532 32,662 73 73
Q68FM7 27,6253 26,2082 26,6919 32,6953 32,8186 32,8563 73 73
Q68FM7 26,9561 27,265 25,5845 33,1527 33,3197 33,459 73 73
Q68FM7 24,6035 24,8462 25,1126 29,2088 29,9048 28,9566 73 73
Q68FM7 23,6502 25,055 23,969 29,2511 30,4178 30,1891 73 73
Q68FM7 27,7403 29,6232 30,2645 32,0944 32,978 33,2457 73 73
Q68FM7 28,4122 28,7026 28,6702 30,7889 31,0835 31,5791 80 80
Q68FM7 28,1474 27,5786 27,485 30,007 29,1453 30,1521 80 80
Q8R4H2 29,8516 24,602 29,9393 33,2988 33,734 33,6016 77 77
Q8R4H2 27,2432 26,8546 25,8668 34,2937 33,9202 33,6519 77 77
Q8R4H2 25,7708 25,3214 26,8723 33,4545 33,6292 33,6119 77 77
Q8R4H2 25,4881 25,2442 25,0199 27,9474 28,8528 29,0529 77 77
Q8R4H2 24,0802 24,6002 24,4918 29,5874 30,5481 30,1224 77 77
Q8R4H2 31,4343 31,7327 31,6196 33,6698 34,1709 34,07 77 77
Q80U35;Q 29,3547 30,6503 30,7424 25,2959 27,4317 27,8442 19 19
Q80U35-2; 29,613 29,6722 29,5418 26,885 26,7104 26,8006 25 25
Q80U35-2; 29,1387 29,1596 28,4739 23,0582 22,9207 24,6684 25 25
Q6P9R4;Q6 24,8948 25,1712 26,0049 27,3968 29,7069 29,8688 20 20
Q6P9R4;Q6 23,7185 24,9447 23,4294 28,5728 29,3683 29,9721 20 20
Q6P9R4;Q6 23,3445 23,1021 22,4562 26,4681 27,3457 27,1846 24 24
Q60875;H3 28,3046 26,4998 26,3564 30,02 29,6779 29,7653 47 47
Q60875;H3 28,0504 27,1375 27,1474 30,268 30,29 30,4339 47 47
Q60875;H3 29,4564 31,0678 31,0776 32,9833 33,6895 33,4717 47 47
Q60875;H3 24,3544 28,2787 26,987 28,7385 31,0224 30,3602 47 47
Q60875;H3 31,6975 31,6064 31,2212 33,3552 33,4995 33,7747 78 78
Q60875;H3 30,6733 30,6965 30,2937 32,4501 31,8412 32,3398 78 78
Q60875;H3 24,2116 20,5982 23,7973 30,5475 30,4382 31,0588 78 78
F6WMJ3;Q 26,2087 25,4498 24,574 29,9964 30,5361 30,4109 23 20
F6WMJ3;Q 24,6054 24,7306 25,9328 29,6826 30,4283 30,3224 23 20
F6WMJ3;Q 25,0346 26,9492 27,3245 31,5935 31,6518 31,9271 23 20
F6WMJ3;Q 25,1856 25,3166 25,6607 30,3216 31,0433 30,6532 23 20
F6WMJ3;Q 24,4002 24,967 25,4784 29,4027 30,6655 30,8441 23 20
Q9ES28;Q9 30,3102 28,7208 27,3787 35,3431 35,4225 35,3608 68 68
Q9ES28;Q9 26,9065 25,9222 25,1191 35,3948 35,2447 35,1034 68 68
Q9ES28;Q9 25,2788 25,8294 25,2457 34,8591 35,1369 35,0312 68 68
Q9ES28;Q9 29,8619 30,496 29,7755 34,5412 35,4402 35,3508 68 68
Q9ES28;Q9 29,0465 29,8161 28,9969 35,8181 35,8452 35,1766 68 68
Q9ES28;Q9 25,1104 24,6964 24,7361 27,5014 27,6791 26,9781 68 68
Q9D0J4 29,1258 28,978 28,3819 27,3874 26,7332 27,0243 10 10
P16460;Q3 24,0716 24,6628 23,5854 26,3806 26,0682 26,5715 2 2
Q8BH66 24,4693 24,6326 23,8939 25,8075 25,778 25,6015 6 6
Q4FK74;Q9 29,6103 30,2947 30,0892 26,4991 25,1975 25,2266 4 4
Q9D1K2;F7 24,3844 25,3281 26,74 22,0192 20,9762 21,3082 4 4
B1AZ47;Q8 23,7399 22,9137 23,7967 21,7572 22,0027 22,0675 8 8
B1AZ45;Q8 24,2545 24,6604 23,7654 30,1236 29,9366 29,829 42 2
Q3UKP6;Q 29,2851 29,4925 29,0407 36,2609 36,2124 36,076 43 43
Q3UKP6;Q 24,7086 24,6286 24,3025 33,3155 33,6748 33,2003 43 43
Q3UKP6;Q 25,612 23,6096 26,1024 35,2293 35,3443 35,431 43 43
O55028;Q3 23,9001 24,4767 24,6109 26,4503 27,7758 27,2593 4 4
Q91VR8 26,9347 26,4047 24,8612 30,5484 32,3383 31,3002 12 12
Q91VR8 27,9279 26,2961 27,3432 32,4582 33,3956 33,1474 12 12
Q91VR8 25,3551 24,8311 25,8092 29,7158 29,3552 27,6497 12 12
Q99N28;E9 25,6469 25,6325 26,3344 27,7118 27,076 27,2922 7 7
Q5SVJ0;P2 25,2587 28,3149 24,4845 28,3106 28,7993 29,3048 21 15
E9PWZ5;P4 24,3836 23,9482 23,0254 27,114 26,9392 26,4841 7 4
D3YZP9 25,4742 25,218 23,8193 27,8081 27,8412 28,1355 2 2
P60766;Q3 25,6322 25,5516 26,1199 24,8245 24,3056 22,9113 3 3
E9PVY0;D3 30,0569 29,8555 29,8382 32,9718 33,571 33,4727 72 64
E9PVY0;D3 27,4929 26,2378 27,6672 30,9188 31,9055 30,5076 72 64
E9PVY0;D3 26,2803 26,0549 24,6337 31,7853 33,2083 32,4922 72 64
E9PVY0;D3 26,3562 25,4182 25,7307 29,5117 30,794 30,7209 72 64
Q7TT50 32,6407 32,5108 32,4814 35,1895 35,3021 35,4176 105 105
Q7TT50 26,3861 27,0178 27,4921 34,0888 34,4611 34,3078 105 105
Q7TT50 28,1775 27,0562 25,3377 34,0413 34,7645 34,5059 105 105
Q7TT50 25,325 25,3016 25,252 28,9928 29,5787 29,6142 105 105
Q7TT50 25,6366 26,3279 25,3289 31,6507 31,8931 32,0661 105 105
Q91W92 29,4228 28,8667 29,3866 30,8549 31,4858 31,6099 14 13
Q91W92 26,9483 26,3836 24,5485 28,4848 29,3655 29,0275 14 13
A2A6Q1;Q 34,1325 33,2844 33,7551 36,0805 35,5699 35,7225 27 27
A2A6Q1;Q 28,6646 27,6649 28,0338 33,0086 32,4042 32,2371 27 27
A2A6Q1;Q 25,1658 24,7431 24,4512 29,3849 29,851 29,9665 27 27
Q8BGH7 25,8599 25,015 24,7582 27,5851 28,4296 28,071 2 2
E9QL53;P4 25,8912 24,2883 23,8924 28,0541 29,3414 29,6081 86 86
E9QL53;P4 26,5625 24,1583 24,5156 28,8382 32,4674 31,7681 86 86
E9QL53;P4 25,5675 26,5388 25,5677 32,7594 33,3739 33,447 86 86
E9QPY8;P4 22,6555 22,1928 21,4416 27,7505 28,0379 28,4545 56 56
E9QPY8;P4 23,1359 25,9143 23,2759 28,5925 26,8592 27,4479 56 56
Q921W4;D 24,6343 25,8541 23,5751 27,9756 28,2648 28,6396 7 7
E9Q8Z8;E9 24,1684 24,2592 24,5918 22,0307 21,8302 23,7358 6 6
Q5SQX6;E9 29,486 29,4056 29,569 32,6156 33,1557 32,6565 51 51
Q5SQX6;E9 27,4273 27,6147 27,7342 30,0165 32,44 32,5691 51 51
Q5SQX6;E9 29,2895 28,9869 29,0917 30,3354 30,7008 30,2344 51 51
Q8BPM0;Q 22,4334 21,0426 23,4721 26,9412 26,8504 27,3198 42 42
Q8BPM0;Q 22,2374 22,6913 23,2914 28,4308 27,445 28,1899 42 42
Q80U19 21,7287 22,1458 20,768 27,3199 27,1019 27,6038 40 38
Q80U19 24,5366 25,1054 25,7554 27,9296 26,9909 27,6771 40 38
Q80U19 23,7007 24,6168 25,2783 26,4338 26,6033 27,4167 40 38
E9PV41;E9 22,4059 21,5128 22,9812 24,6145 24,0463 23,7535 12 12
E9Q4U7;Q 25,2775 25,6037 25,5929 27,9213 29,2786 28,8453 17 17
E9Q4U7;Q 24,8192 24,7554 24,5957 28,577 28,7168 29,3162 17 17
Q3UWU7;Q 27,3467 27,2148 27,2704 26,0923 25,7934 26,2217 9 9
E9QMR2 26,7636 25,909 26,5362 28,8742 31,0816 29,3813 80 80
E9QMR2 25,4659 26,3907 25,5215 30,2518 33,089 32,4595 80 80
E9QMR2 23,5209 24,8519 24,2843 30,5771 31,3431 30,8044 80 80
A2BFF9;Q3 24,0001 26,0386 23,1049 26,7593 27,2578 27,1415 6 6
B2KGQ2;Q 24,8118 24,7341 29,2702 30,5852 29,2539 29,7256 4 4
B2KGQ2;Q 28,6307 28,6385 24,6044 30,8962 30,7811 30,1585 4 4
O35459 21,5872 21,9357 20,5006 24,1112 22,9421 22,8557 5 5
Q9D9V3;Q 24,6253 26,2448 26,1497 29,1837 29,8085 29,3013 14 14
Q9D9V3;Q 25,6335 25,0583 24,5737 28,4749 28,9504 29,2432 14 14
P62631;B7 35,7865 35,3184 35,6441 31,6667 31,6249 31,8712 46 46
P62631;B7 36,0333 35,6234 35,0792 31,4784 31,1382 31,3606 46 46
P62631;B7 34,5191 34,4589 34,5626 31,9486 31,3838 31,4715 46 46
P63242;Q8 27,8239 27,8921 27,915 26,7966 26,7094 26,6782 5 5
F8WIL9;Q8 28,5222 29,4792 29,1635 30,0859 31,1191 31,1439 29 21
Q8BHL5-2; 29,324 29,9195 29,8331 30,6423 32,4272 32,1908 32 32
Q8BHL5-2; 28,4377 29,3808 29,6772 30,4449 32,0849 31,7418 32 32
Q60902;F8 30,7094 31,0854 31,307 28,6961 29,3507 29,6265 31 31
Q6KAR6;Q 21,7289 21,8582 22,7144 24,2711 23,6738 24,2965 12 12
Q3UQY4;Q 23,3339 23,1331 23,8709 22,3654 22,4522 21,7273 3 3
G5E8A2;Q6 25,444 28,5469 28,1 29,5296 30,7768 30,3426 19 19
G5E8A2;Q6 25,8624 23,7925 26,5588 27,7279 28,6813 29,88 19 19
G5E8A2;Q6 22,2242 22,052 22,8074 28,3944 28,2592 28,099 33 33
G5E8A2;Q6 23,7906 23,4956 23,3019 29,24 28,208 28,8648 33 33
Q80U16 21,8925 22,8338 22,5303 25,634 25,9257 26,1643 17 16
Q9QUI1;Q7 26,6737 26,2483 24,2258 28,7993 29,1497 28,9244 6 6
P97807;P9 29,5662 30,0569 29,8223 31,1197 31,0364 31,3478 21 21
P45878;Q3 23,5573 24,5892 23,8033 21,9972 21,6691 22,2384 3 3
Q80TY0;A2 26,8729 26,8492 26,6829 28,3243 28,6258 28,9448 21 21
Q80TY0;A2 24,8992 25,3817 23,8405 29,9448 29,6868 29,6418 21 21
Q80TY0;A2 26,272 24,7208 24,9743 31,4474 31,2554 31,4471 21 21
Q80TY0;A2 25,6012 26,5199 25,7575 28,442 28,809 29,2503 21 21
E9PUK3 26,4507 26,3635 26,4721 30,3168 30,7844 30,8623 30 30
E9PUK3 24,8079 25,6061 25,9209 31,3869 31,4081 31,8154 30 30
E9PUK3 24,6504 23,9053 24,8415 31,5084 31,5989 31,6399 30 30
Q9WV18;Q 23,4193 23,8369 23,2372 22,129 21,9444 21,849 6 6
P48320;Q5 26,932 26,2931 26,944 24,9126 23,9053 24,9149 4 3
Q64737;Q3 27,075 27,1792 27,2772 26,2262 25,9909 25,9981 6 6
O88741 21,7151 22,1419 23,3097 24,26 24,642 23,7256 9 9
Q68FF6 30,669 30,4246 30,3414 34,4125 35,2557 35,0532 52 52
Q68FF6 26,7686 28,7085 29,1668 34,9429 35,2101 34,8323 52 52
Q68FF6 25,3936 25,2601 26,9222 33,8362 34,0143 34,3625 52 52
Q68FF6 30,2404 30,9826 31,2049 34,4692 35,6106 35,3668 52 52
Q68FF6 29,2627 29,8381 29,3633 34,5658 34,991 34,5657 52 52
E9PVA6;Q8 24,1284 24,976 24,6117 28,7769 29,7737 29,7308 29 25
E9PVA6;Q8 24,8404 25,7943 25,4007 32,2496 31,8891 32,271 29 25
E9PVA6;Q8 25,3501 25,5801 24,2166 28,8933 30,3188 30,2948 29 25
E9PVA6;Q8 27,4418 28,0044 28,0593 33,5332 34,2057 33,2716 29 25
P18872;Q5 30,0842 30,4096 30,0818 31,6102 31,5894 31,3887 25 25
A2AEG6;P3 22,8752 22,7993 24,5803 25,3159 25,672 25,6886 8 8
Q4VAB2;Q 23,6736 24,6222 24,2908 21,5675 22,8632 22,1724 5 5
Q3U5I5;Q6 25,7189 26,3917 27,6503 29,113 29,0201 28,4785 16 16
B2RTN5;Q9 23,5303 25,2297 24,4283 29,0699 28,6952 28,971 9 9
A2AL35;P1 21,5814 21,8497 22,6028 23,2127 23,1107 23,8207 6 6
Q8K013;F8 25,0414 25,4239 25,1173 21,2788 22,1144 23,3455 6 6
F8VQK3 22,2567 23,0778 23,5097 24,7991 24,8129 25,0491 11 11
Q3U4H6-2 22,0772 22,4765 22,5918 24,5845 24,6487 24,8377 8 8
Q99JP6-2;Q 30,7453 29,7738 30,0597 34,4051 33,2249 33,2312 26 26
Q99JP6-2;Q 31,1258 29,4441 28,6973 35,5093 34,736 34,2858 26 26
Q99JP6-2;Q 31,7488 30,1166 29,7076 34,266 33,3478 33,2909 26 26
Q4KL76;Q6 28,3777 28,0492 27,9576 25,2146 27,2744 25,3971 8 8
D3YXH0;P6 27,3127 28,2214 28,0455 25,0954 26,9453 25,9199 4 4
Q9DCE9 21,9688 21,1691 22,0057 24,0127 24,294 24,0563 6 6
Q6P549 23,8183 23,781 24,8866 28,214 28,9828 29,1427 17 17
Q6P549 24,2768 25,9508 25,6862 26,7167 29,0198 28,9018 17 17
Q6P549 24,3065 24,4596 24,2335 28,3001 28,7914 28,2373 17 17
Q6P549 23,2974 23,6141 21,5945 25,1865 24,8417 25,1202 16 16
Q6P549 23,2462 23,5404 22,1356 26,3622 25,1747 25,7342 16 16
E9QAD8;A4 23,4165 25,0666 24,3519 27,5055 27,5881 28,0491 6 6
Q3TES0;D6 25,2962 23,9398 24,0218 26,9668 28,0685 27,4001 7 7
Q3TES0;D6 25,5886 25,2 26,5198 28,8083 30,5925 29,6802 7 7
Q3TES0;D6 26,7964 23,9354 23,9357 30,047 30,8797 30,5713 7 7
Q3TES0;D6 24,2793 23,4818 25,4268 28,7406 27,6242 28,8766 7 7
Q9DCB8 28,1842 27,9155 28,9502 24,7482 23,63 25,5393 4 4
A2CG49-7; 30,4872 32,0608 31,5368 28,3771 28,9949 28,6462 34 27
E0CXZ9;P6 27,0485 27,1837 26,8076 25,1362 24,8906 24,74 8 8
E0CZ72;P2 22,6143 23,7449 24,6386 26,2237 26,8469 26,4219 8 8
Q8VED9 24,0601 24,4981 24,0772 21,8087 22,2815 21,5976 4 3
Q8JZS0 24,3422 25,4622 26,4592 28,1874 27,9572 27,5165 9 9
Q80Y17 24,8048 25,4692 25,3773 28,9614 29,1265 28,478 13 13
Q80Y17 25,1101 25,5766 25,2908 28,5618 29,5483 29,1695 13 13
F6SY09;P55 22,9438 23,7171 22,7882 24,581 24,6464 24,3245 7 7
E9PV22;B1 21,1778 22,6456 22,4218 23,6412 24,0083 23,4751 7 7
Q8K2P1 25,1543 24,4858 23,6295 29,2643 29,0212 28,9703 7 7
B1AV56;Q9 26,3264 25,6863 26,3452 23,682 24,1959 24,598 7 7
P27546;P2 23,6078 24,5593 24,0605 22,7691 22,6621 22,367 17 7
Q99LB6;Q9 26,7537 26,5584 26,5154 24,392 25,3393 24,2095 5 5
Q99MR8;F 26,5393 26,9451 27,3279 24,9025 24,4329 25,0981 9 9
Q8C436;Q8 24,9223 24,5835 23,9549 29,1376 26,212 27,0654 7 7
F8WGE8;Q 21,4966 21,0324 21,7429 23,341 23,8792 24,2808 13 13
Q3V100;Q9 24,2618 23,8444 23,8456 21,7622 22,0741 22,4286 7 7
P70290;Q5 25,6025 26,4966 26,4011 23,164 24,2782 23,0919 8 8
F6XPV7;F6 20,8556 21,2217 21,7769 23,8457 23,1693 24,3253 5 4
Q60605;Q6 26,7827 28,0026 27,1588 28,8738 29,7723 29,1161 9 9
Q9CQ25 24,4898 24,0945 23,2866 26,4393 26,8373 27,05 3 3
Q9CQ25 24,726 24,2074 23,4173 27,9468 28,6234 28,7223 3 3
Q91X97;D3 27,3977 27,4126 27,4171 23,7081 24,6255 23,9134 7 4
Q8BLF1 28,2411 27,6272 27,4797 25,5996 24,7103 24,6456 5 5
Q8BLF1 25,9224 25,8058 25,4329 26,8506 26,5643 26,9618 13 13
A2AS98;A2 29,23 28,9982 28,8523 32,9192 34,5641 33,5494 59 59
A2AS98;A2 25,9991 25,7203 26,1107 32,1372 33,9234 33,13 59 59
Q62425 30,6551 30,2364 30,6608 28,8495 28,8409 28,7219 8 8
Q9DCJ5 27,1347 27,2082 27,4168 25,0207 23,9332 23,8632 7 7
Q91WD5;D 22,4135 21,8375 21,5786 23,0328 24,8239 24,5089 5 5
P19246;F7 25,1889 24,4588 23,8874 28,3267 28,0597 27,0139 11 8
Q6P3D0 27,1795 27,8131 27,0284 23,8232 23,4129 22,6138 13 13
Q6P3D0 26,767 27,2961 26,6223 20,3651 22,8614 23,8606 13 13
Q6P3D0 25,6076 26,8576 26,4079 22,3146 22,4351 22,6829 13 13
P58281-2;P 30,1642 30,2141 30,3218 31,3672 32,0048 31,8159 50 50
P58281-2;P 29,279 29,5079 29,0826 31,6771 31,6041 31,5468 50 50
P58281-2;P 28,5179 28,1339 27,6163 32,2522 32,0275 31,8102 50 50
P58281-2;P 30,2445 30,0441 30,2225 32,3552 33,1811 32,9239 50 50
P58281-2;P 29,5431 29,8907 28,6778 32,2043 32,9169 32,1939 50 50
Q3TDA7;Q 29,2422 30,0201 30,4246 25,7257 24,0689 25,5135 16 14
Q3TDA7;Q 29,0054 29,372 28,831 24,1109 24,9511 25,4187 16 14
G5E884;O8 32,7505 32,6441 32,7858 35,9129 36,1638 36,059 42 42
G5E884;O8 31,0777 32,0078 31,6831 34,8872 35,2617 35,2873 42 42
G5E884;O8 31,4419 31,9578 30,7591 35,3169 35,3904 35,4967 42 42
G5E884;O8 30,25 30,2534 30,4937 32,5848 33,3663 33,1777 42 42
G5E884;O8 28,6729 28,0246 29,0213 32,2142 32,6772 32,1397 42 42
Q8CIN4 30,4934 29,5585 29,3035 32,5716 32,6619 32,8163 27 15
Q8CIN4 28,9489 28,118 28,8174 32,6399 32,6133 32,7167 27 15
Q8CIN4 27,944 27,3459 26,6813 32,9282 33,504 32,772 27 15
Q8CIN4 25,1332 24,7275 26,5235 29,8237 31,0223 30,9257 27 15
A3KGC1;Q6 31,9759 32,4468 31,2745 33,9588 34,0217 34,2668 37 21
A3KGC1;Q6 31,5662 31,305 31,9686 33,9087 33,8959 33,8915 37 21
A3KGC1;Q6 29,197 29,6864 28,5726 32,8029 33,3348 32,7714 37 21
A3KGC1;Q6 28,6119 28,1588 28,3546 31,975 32,2548 31,9815 37 21
A3KGC1;Q6 25,7301 25,1339 25,8056 29,0097 30,2621 29,556 37 21
Q8BTW9 26,0078 25,8113 26,1093 28,1603 28,4836 27,817 9 9
Q3ULB5 23,8585 24,028 24,4668 25,473 25,9748 26,043 3 2
B1AYC2;Q8 26,9726 26,8098 27,0364 28,1576 28,3827 28,259 8 7
Q9Z101;D3 25,0309 24,9168 25,1567 28,6065 27,068 26,308 7 7
Q9Z101;D3 23,8762 24,5273 24,489 25,7401 27,0952 25,8793 7 7
Q8BFQ8 25,3066 24,2893 24,7663 27,8407 28,7127 27,7418 4 4
O55057;Q3 24,3372 24,2485 24,7024 23,5013 23,1515 23,3969 4 4
E9Q3L2 24,0336 24,368 23,4257 25,1344 25,5655 25,0808 22 22
Q8BTI9 25,4108 24,1283 24,8687 26,9053 28,2008 28,385 11 11
P26450;Q8 25,3896 25,9067 26,1492 28,8041 29,0871 30,2447 11 11
P26450;Q8 24,2941 24,2735 25,317 28,1002 29,6719 29,3613 11 11
P26450;Q8 25,7579 25,7876 25,4961 27,6735 27,4981 27,944 11 11
P26450;Q8 23,9916 24,4784 23,2036 27,4417 27,4518 27,5346 11 11
Q3UJ95;Q8 26,9225 25,2787 23,9653 27,663 27,9356 28,0024 9 9
P70268-2;P 24,3829 25,3213 25,1449 27,7427 29,6541 28,8216 18 18
P70268-2;P 22,9373 23,538 22,9715 25,0984 24,2372 25,612 13 13
P70268-2;P 22,3595 21,5714 22,3414 24,5308 23,7728 24,032 13 13
G3X9A7;Q8 22,4302 22,3442 22,236 25,3023 23,7232 25,0118 8 8
O35405 28,1181 28,2649 27,9241 27,2295 24,9715 24,432 5 5
Q66T02;B1 26,4431 23,4091 24,4345 28,4534 29,0858 29,358 8 8
Q66T02;B1 24,7063 24,5894 25,3936 27,7765 27,943 29,0536 30 30
Q66T02;B1 26,8178 27,0164 26,4948 28,5445 28,1401 28,9183 30 30
Q8CJH3 25,3195 23,0082 25,4993 26,6726 28,1129 27,8022 5 5
B2RXS4;E9 23,5105 24,1338 22,9912 26,4725 25,7856 26,3537 14 14
Q91XF0 22,1407 21,8915 22,0549 24,484 24,9748 24,3284 6 6
Q3UYC0;Q 27,3279 27,6946 27,6969 28,7748 28,5417 28,9593 16 16
P62137;Q3 25,3686 25,6275 24,5916 27,7456 27,7902 27,7677 9 9
Q3TDD9 25,6834 25,3034 26,3567 29,1523 30,1264 28,8315 14 14
Q3TDD9 24,1234 23,9825 23,7306 27,9843 28,6731 28,717 14 14
Q60996;Q6 21,7732 22,5216 23,9882 24,9253 25,035 24,7231 8 8
Q69ZK0 28,1534 27,8774 28,5158 24,1872 23,6294 24,8871 11 11
Q5DTK3;Q 25,9325 26,0665 25,8582 27,0664 28,1822 27,7466 8 8
Q5DTK3;Q 26,0743 24,6683 25,8402 27,1433 27,1655 27,8986 8 8
Q6PE13 21,8219 22,0098 21,682 23,249 23,0874 22,9114 3 3
Q8C0E9;E9 22,1836 21,4465 22,9206 23,3768 23,6161 24,1834 5 5
Q9QUM9;E 26,5461 26,9513 26,197 24,7349 24,4033 24,791 5 5
Q9CR00 24,1841 24,902 23,8323 26,3893 26,0277 26,041 4 4
P97372;Q5 22,3598 22,6346 22,5312 24,1839 23,7274 24,0096 5 4
P62827 29,7327 29,7655 29,9168 27,9163 27,3894 27,6063 18 18
P62827 30,2343 29,8905 29,2494 27,9795 28,0416 27,9459 18 18
P62827 29,3426 29,498 29,2378 27,584 28,0753 27,2519 18 18
Q52L50;Q9 22,4866 22,4953 23,8563 25,4138 24,4895 25,2423 6 6
E9Q912;E9 31,5589 30,6844 30,6046 29,2318 28,7537 28,9112 27 27
F2Z408;G5 23,2059 24,7232 23,6093 27,2371 27,3054 27,6028 8 8
Q9JJ43-3;Q 21,872 21,3311 22,5293 24,1536 24,0189 24,3508 12 2
P97492 27,0299 25,2866 25,0275 28,3647 28,2824 28,7287 12 12
P97492 25,9668 25,954 25,8819 29,2711 29,6579 29,4308 12 12
P97492 25,7741 26,0432 26,5949 27,7144 28,4099 28,146 12 12
Q8BWR8 21,9053 22,9494 21,6192 23,9762 23,7046 24,9162 12 12
P70335;P7 21,0926 22,8838 21,874 23,6673 23,9162 24,1253 13 7
F8VPK5;P7 26,1883 26,4891 23,2215 29,0742 29,0721 29,8596 78 78
F8VPK5;P7 26,7955 25,622 26,3999 29,2431 28,0968 28,2774 78 78
F8VPK5;P7 25,3277 26,7337 26,4013 29,8978 32,1701 31,7473 78 78
F8VPK5;P7 26,5603 27,0314 28,176 33,6193 34,0758 34,0645 78 78
E9PYM9;F8 26,0174 26,0218 26,1176 29,4731 29,389 28,9697 65 65
E9PYM9;F8 26,4132 25,7472 26,7987 29,8985 28,6115 29,1193 65 65
P67984;Q4 25,3611 24,7334 25,3805 22,7747 22,4312 23,6978 5 3
Q6ZWU9;E 28,312 27,2619 28,1822 25,8787 25,4772 26,0668 3 3
Q8C6B2-2; 26,2945 25,9151 25,1475 27,2295 28,5938 28,3772 12 12
Q8C6B2-2; 24,8242 26,3305 27,0496 27,8266 29,0406 29,7056 12 12
Q8C6B2;Q8 22,0756 21,9931 22,2584 23,494 23,4639 23,1574 4 4
Q3UXS0;O3 22,7436 22,0311 23,057 23,8206 23,8109 24,0462 4 4
Q8R127;D3 25,1334 24,5764 23,8885 26,7529 26,6197 26,8021 3 3
P28661;P2 27,9252 28,1864 29,0163 30,3045 29,9054 30,9384 16 14
E9Q9F5;O5 31,0877 31,1349 30,0115 32,3458 32,4577 32,2702 22 22
B1AQZ0;B1 27,9132 28,8357 28,0801 29,6569 31,1264 31,5157 18 13
Q80UK0 24,861 26,1062 25,2564 27,1763 28,6002 28,0432 13 13
Q80UK0 25,0818 25,3553 25,3175 29,178 29,7191 29,4859 13 13
Q80UK0 25,3998 24,8792 24,3288 27,1379 27,8642 27,8634 13 13
Q69ZI1;E9Q 24,7767 24,0347 23,2971 26,7889 27,6309 27,3724 4 4
Q9DB41;Q 27,3016 26,7142 27,1005 24,0864 24,8316 25,8527 6 3
O54988;A2 24,2853 25,7165 26,1147 26,7927 28,6999 28,3995 10 10
Q61548;Q6 25,0771 26,2796 25,2908 27,2923 29,5633 28,4756 16 16
Q3UHD6;Q 22,1333 22,2157 22,9702 23,7826 24,5004 24,3745 11 11
Q8C0J6 24,385 25,7524 25,6146 27,3265 27,0277 27,0871 8 8
Q8C0J6 24,4714 24,6497 24,098 27,8726 27,5376 27,5053 8 8
F8VPQ4;Q8 24,473 24,6051 24,5638 25,5182 26,8393 26,54 5 5
P14576;E9 24,4893 25,1576 23,8925 21,3858 22,806 23,0729 13 13
Q99L47;F8 22,8326 24,0456 24,7776 27,4588 26,7371 27,1053 7 7
P70297;Q3 25,9608 26,8008 27,544 25,1568 23,6733 24,3256 3 3
E9QM25;Q 21,3674 22,4256 21,9938 23,1476 23,1935 23,7792 3 3
P63046;P6 24,8363 25,2037 23,941 27,673 28,1865 28,8375 5 5
F8WGK2 28,4191 30,6554 30,4025 26,1446 27,9568 24,7002 5 5
Q6ZQ29-2; 25,5207 25,8112 25,5467 28,1032 27,0689 27,3901 9 9
Q6ZQ29-2; 24,6483 23,9438 24,9669 26,8854 27,0973 27,1562 9 9
Q6ZPF3;Q6 29,3082 29,8391 30,1726 26,1086 27,1434 26,8295 14 14
F8WJF7;Q8 27,6809 29,1111 27,4231 25,2887 25,8054 26,1876 4 4
Q9R1R2;Q3 26,2773 25,4919 25,0893 28,0003 28,1931 28,5507 17 17
Q9R1R2;Q3 24,3475 24,9908 24,517 28,8114 28,2975 28,4197 17 17
Q0KL02-4;Q 30,8915 32,2817 32,074 28,5354 29,7782 29,4747 38 38
Q8CJ53;Q8 27,117 27,4383 25,5746 30,4841 31,0674 30,8689 20 20
Q8CJ53;Q8 24,9423 24,2383 26,1101 30,7368 30,5384 31,1146 20 20
Q8CJ53;Q8 25,0645 26,4126 22,8407 30,8079 30,6976 30,7443 20 20
Q545E6;Q6 23,0731 22,2853 23,1057 26,2791 26,0898 26,1207 6 6
Q9QZE7 22,3383 21,8759 22,9996 23,7003 25,4824 23,9485 9 9
Q9CR09 23,6312 23,4912 23,0902 22,1618 21,9063 22,0253 4 4
Q8R5H6 29,3197 28,521 29,7536 33,0654 33,8916 33,4645 24 24
Q8R5H6 27,5362 25,8656 26,0234 31,8696 31,8488 31,8638 24 24
Q8R5H6 28,2054 28,2571 28,4662 30,6383 30,3708 30,2835 24 24
Q8VHI6 27,3739 26,7503 26,7262 31,1943 32,3378 32,2341 15 15
Q8VHI6 25,7375 27,7191 26,4006 32,7701 33,2671 33,032 15 15
Q8VHI6 26,6606 26,8048 26,3279 28,0436 27,9725 28,0166 15 15
Q3TXX8;Q9 31,7529 32,0837 32,3153 34,1241 34,7047 34,3238 32 32
Q3TXX8;Q9 29,3043 28,6118 29,3082 33,8514 33,8378 33,8747 32 32
Q3TXX8;Q9 28,1433 29,9051 29,1246 34,6893 34,7172 34,7513 32 32
E9Q1S7;P9 27,2398 27,4344 27,1614 24,7197 22,9878 24,6674 4 4
A2ATB9;Q8 25,043 24,2741 25,249 28,9368 28,916 28,7133 6 6
Q6PEV3 27,3378 28,3613 29,3083 32,7319 32,8431 31,4298 29 29
Q6PEV3 29,1067 29,8339 28,9539 33,5494 33,4693 33,6285 29 29
Q6PEV3 27,4625 26,8181 26,0282 31,9032 31,5362 32,2731 29 29
P0C7L0;E9 29,0374 29,6961 29,2648 32,4668 32,3234 32,3164 17 17
P0C7L0;E9 29,0157 30,4487 28,9732 33,1523 32,9859 33,2298 17 17
P0C7L0;E9 24,9355 25,1631 25,4076 30,3987 29,7998 29,9994 17 17
Q8C3W1 24,4117 24,505 24,7764 27,5458 27,7489 27,6485 12 12
Q80U16-5; 21,9288 23,2 22,2916 23,3022 24,3688 25,0613 15 3
Q8C3W1 24,1401 23,8173 24,0772 26,804 26,8843 27,7556 19 19
Q8C3W1 25,8105 25,364 25,3513 27,3169 26,7236 27,4353 19 19
Q8C3W1 25,1438 25,463 25,215 26,7933 26,3659 26,803 19 19
Unique pepSequence c  Mol. weigh  Sequence l PEP Intensity Proteins -Log t-test p va t-test Diffe
9 49,4 25,83 239 2,05E-58 6,17E+08 2 1,53832 2,82228
9 49,4 25,83 239 2,05E-58 6,17E+08 2 2,21896 3,9198
9 49,4 25,83 239 2,05E-58 6,17E+08 2 3,3915 2,49764
8 47,1 28,152 244 7,68E-43 1,63E+09 2 2,077 -2,29053
15 44,1 52,287 481 0 2,14E+10 15 3,89665 4,14041
15 44,1 52,287 481 0 2,14E+10 15 4,37118 6,05094
15 44,1 52,287 481 0 2,14E+10 15 2,5273 1,53206
15 44,1 52,287 481 0 2,14E+10 15 1,84488 2,55006
14 44,8 49,387 446 0 1,07E+10 2 4,74953 5,15818
14 44,8 49,387 446 0 1,07E+10 2 3,76298 6,39705
14 44,8 49,387 446 0 1,07E+10 2 2,07479 2,28479
9 21,7 98,987 859 1,91E-44 5,56E+08 8 1,52354 2,12188
16 41,9 47,907 430 0 3,94E+09 1 3,49919 3,38787
16 41,9 47,907 430 0 3,94E+09 1 3,85202 3,43732
16 41,9 47,907 430 0 3,94E+09 1 3,79269 4,07868
32 84 44,816 424 0 2,79E+11 1 4,87644 4,14807
32 84 44,816 424 0 2,79E+11 1 4,9233 5,97495
24 64,9 44,816 424 0 8,29E+10 1 3,07268 1,88783
24 64,9 44,816 424 0 8,29E+10 1 3,32401 2,13176
6 17,4 41,297 397 3,04E-12 5,19E+08 4 3,88716 2,48226
5 9,9 93,042 837 6,05E-39 8,31E+08 8 3,74882 2,62959
12 7,1 306 2776 6,95E-44 5,61E+08 7 1,7925 3,17257
11 12,4 122,79 1121 1,83E-88 7,24E+08 1 1,92447 2,05678
11 12,4 122,79 1121 1,83E-88 7,24E+08 1 1,52939 3,05488
6 65,2 20,601 181 0 1,04E+10 11 1,97796 -2,30203
28 18,3 229,72 2089 3,55E-253 4,62E+09 7 2,4285 5,44331
28 18,3 229,72 2089 3,55E-253 4,62E+09 7 4,15039 5,78996
28 18,3 229,72 2089 3,55E-253 4,62E+09 7 4,51887 4,05938
31 21,4 229,72 2089 1,83E-293 1,15E+10 7 2,66196 2,76102
31 21,4 229,72 2089 1,83E-293 1,15E+10 7 2,72741 3,72379
48 43,2 172,47 1503 0 8,1E+09 2 2,3863 2,03378
48 43,2 172,47 1503 0 8,1E+09 2 1,84364 5,00985
48 43,2 172,47 1503 0 8,1E+09 2 4,48262 6,68706
48 43,2 172,47 1503 0 8,1E+09 2 2,17097 5,43348
48 43,2 172,47 1503 0 8,1E+09 2 3,4975 5,75175
23 19,6 172,47 1503 1,10E-104 2,06E+09 2 2,8785 2,42991
23 19,6 172,47 1503 1,10E-104 2,06E+09 2 2,21465 2,55146
13 67,2 23,407 204 0 1,45E+10 1 3,25707 -1,96296
13 67,2 23,407 204 0 1,45E+10 1 1,85464 -4,43133
13 67,2 23,407 204 0 1,45E+10 1 2,8735 -2,19356
14 60,8 23,407 204 0 3,88E+10 1 2,09814 -1,17724
33 46,2 109,25 920 0 6,91E+09 8 1,14772 4,61158
33 46,2 109,25 920 0 6,91E+09 8 2,88653 6,02028
49 52,9 108,69 976 0 2,18E+10 8 4,05268 2,07102
  rometry Statistics
 
                          interactions were identified with LF-qGAP. A number of interactions were 
    
4 61,5 171,8 1552 0 3,66E+10 2 4,81635 4,70642
4 61,5 171,8 1552 0 3,66E+10 2 3,84594 5,9483
4 61,5 171,8 1552 0 3,66E+10 2 3,66862 6,70859
4 61,5 171,8 1552 0 3,66E+10 2 3,83286 4,50265
4 61,5 171,8 1552 0 3,66E+10 2 3,30292 5,72796
4 61,5 171,8 1552 0 3,66E+10 2 1,88945 3,5634
6 56,6 171,8 1552 0 3,88E+10 3 3,29949 2,5555
6 56,6 171,8 1552 0 3,88E+10 3 2,24422 2,03114
2 61,6 172,35 1543 0 6,97E+10 1 1,42404 5,41382
2 61,6 172,35 1543 0 6,97E+10 1 4,07341 7,30041
2 61,6 172,35 1543 0 6,97E+10 1 4,08441 7,57708
2 61,6 172,35 1543 0 6,97E+10 1 3,11044 3,36696
2 61,6 172,35 1543 0 6,97E+10 1 4,23301 5,69524
2 61,6 172,35 1543 0 6,97E+10 1 3,75773 2,37471
19 13 221,67 2057 0 5,03E+09 2 1,69479 -3,3919
25 30 114,37 2057 0 9,56E+09 2 5,82285 -2,81034
25 30 114,37 2057 0 9,56E+09 2 3,05334 -5,37496
20 27,6 114,33 1021 2,32E-182 2,17E+09 3 1,86327 3,63385
20 27,6 114,33 1021 2,32E-182 2,17E+09 3 2,98946 5,27357
23 29,4 114,33 1021 5,22E-134 1,74E+09 3 3,35805 4,03187
47 55,8 111,97 985 0 3,68E+10 17 1,91751 2,76746
47 55,8 111,97 985 0 3,68E+10 17 3,14584 2,88552
47 55,8 111,97 985 0 3,68E+10 17 2,10325 2,84754
47 55,8 111,97 985 0 3,68E+10 17 1,22775 3,50038
78 68,3 111,97 985 0 3,13E+11 17 3,35778 2,03478
78 68,3 111,97 985 0 3,13E+11 17 2,71691 1,65589
78 68,3 111,97 985 0 3,13E+11 17 2,59978 7,81244
8 38,7 89,811 795 0 4,71E+09 4 3,2187 4,90366
8 38,7 89,811 795 0 4,71E+09 4 3,32676 5,05483
8 38,7 89,811 795 0 4,71E+09 4 2,74557 5,288
8 38,7 89,811 795 0 4,71E+09 4 4,51418 5,28509
8 38,7 89,811 795 0 4,71E+09 4 3,20487 5,35555
0 81,9 97,055 862 0 9,39E+10 4 2,82661 6,57224
0 81,9 97,055 862 0 9,39E+10 4 4,22224 9,26503
0 81,9 97,055 862 0 9,39E+10 4 5,89005 9,55775
0 81,9 97,055 862 0 9,39E+10 4 3,80543 5,06625
0 81,9 97,055 862 0 9,39E+10 4 4,29091 6,32679
0 81,9 97,055 862 0 9,39E+10 4 3,2874 2,5386
10 50,5 20,864 184 5,63E-128 2,11E+10 1 2,41571 -1,78023
2 11,2 46,584 412 5,20E-58 3,04E+08 2 2,53586 2,23347
6 14,5 63,377 558 9,21E-28 4,23E+08 1 2,40935 1,3971
4 41,1 17,6 168 3,47E-234 1,48E+10 3 3,10693 -4,35699
4 32,8 13,37 119 1,89E-12 2,74E+09 2 2,24375 -4,04965
8 17 59,236 535 4,12E-18 7,98E+08 9 2,16409 -1,54096
2 78,8 53,274 390 0 1,32E+09 2 4,52038 5,73629
3 77,6 57,595 522 0 8,52E+10 7 5,97402 6,91036
3 77,6 57,595 522 0 8,52E+10 7 5,90223 8,85031
3 77,6 57,595 522 0 8,52E+10 7 3,74294 10,2269
4 11,7 46,587 412 2,43E-11 1,84E+08 3 2,51237 2,83259
12 88 8,7608 75 0 1,24E+10 1 2,55852 5,32876
12 88 8,7608 75 0 1,24E+10 1 3,332 5,81134
12 88 8,7608 75 0 1,24E+10 1 2,16473 3,57511
7 30,8 42,964 396 4,18E-203 1,58E+10 2 2,12704 1,48876
10 47,4 72,902 666 0 1,42E+10 10 1,08767 2,78551
4 32,4 33,328 286 5,87E-72 5,3E+08 3 2,64031 3,06002
2 7,2 52,938 469 1,40E-07 7,07E+08 1 2,38181 3,09112
2 20,4 21,258 191 8,87E-37 1,04E+09 2 1,36948 -1,75411
64 45,7 196,92 1732 0 1,66E+10 10 4,17849 3,42163
64 45,7 196,92 1732 0 1,66E+10 10 2,53861 3,97801
64 45,7 196,92 1732 0 1,66E+10 10 3,31244 6,83894
64 45,7 196,92 1732 0 1,66E+10 10 3,08 4,50713
96 63,9 194,75 1713 0 6,54E+10 15 5,33083 2,75875
96 63,9 194,75 1713 0 6,54E+10 15 4,57021 7,32055
96 63,9 194,75 1713 0 6,54E+10 15 3,05356 7,58008
96 63,9 194,75 1713 0 6,54E+10 15 4,45434 4,10236
96 63,9 194,75 1713 0 6,54E+10 15 4,35733 6,1055
13 39,1 43,095 409 6,04E-57 8,87E+08 1 2,68111 2,09148
13 39,1 43,095 409 6,04E-57 8,87E+08 1 1,75695 2,99913
26 82,5 37,869 349 0 2,65E+10 4 2,69844 2,06691
26 82,5 37,869 349 0 2,65E+10 4 3,53452 4,42884
26 82,5 37,869 349 0 2,65E+10 4 4,26232 4,9474
2 66,7 9,2234 84 6,77E-124 3,77E+09 1 2,61706 2,81757
86 39,9 235,36 2055 0 2,8E+10 11 2,28721 4,3106
86 39,9 235,36 2055 0 2,8E+10 11 1,94414 5,94572
86 39,9 235,36 2055 0 2,8E+10 11 4,31828 7,30212
1 28,9 238,82 724 6,00E-276 6,13E+09 8 3,89847 5,98439
1 28,9 238,82 1552 6,00E-276 6,13E+09 8 1,56353 3,52454
7 25,9 38,725 348 8,65E-32 4,05E+08 6 2,20272 3,60551
6 6,8 108,17 967 3,95E-13 8,56E+08 19 1,36596 -1,80756
32 45,9 145,66 1253 0 1,57E+10 6 4,29573 3,32237
32 45,9 145,66 1253 0 1,57E+10 6 2,09145 4,08314
32 45,9 145,66 1253 0 1,57E+10 6 2,83264 1,30088
40 41,3 123,37 1077 0 7,15E+09 3 2,55703 4,72112
40 41,3 123,37 1077 0 7,15E+09 3 3,61524 5,28185
38 42,1 128,37 1115 1,69E-201 8,6E+09 2 3,7438 5,79436
38 42,1 128,37 1115 1,69E-201 8,6E+09 2 2,22492 2,40004
38 42,1 128,37 1115 1,69E-201 8,6E+09 2 1,85124 2,28601
12 13,3 140,4 1264 4,42E-36 9,84E+08 7 1,68238 1,83812
17 25,8 125,41 1102 6,03E-135 7,56E+08 6 2,81529 3,19038
17 25,8 125,41 1102 6,03E-135 7,56E+08 6 4,20832 4,14663
9 45,2 22,498 199 1,17E-50 6,09E+09 2 3,14122 -1,24151
3 47,9 234,91 2058 0 1,24E+10 1 2,0386 3,37612
3 47,9 234,91 2058 0 1,24E+10 1 2,59809 6,14076
3 47,9 234,91 2058 0 1,24E+10 1 3,93291 6,68916
6 21,5 71,424 638 2,79E-145 1,01E+09 7 1,41242 2,67162
2 34,8 10,35 89 3,83E-26 9,08E+09 4 1,0874 3,58289
2 34,8 10,35 89 3,83E-26 9,08E+09 4 1,14591 3,32073
5 23,9 36,118 327 7,18E-14 3,67E+08 2 1,52909 1,96183
14 57,8 35,467 322 4,17E-142 8,93E+08 3 2,59458 3,75795
14 57,8 35,467 322 4,17E-142 8,93E+08 3 3,25336 3,80102
25 71,5 50,454 463 0 1,47E+12 2 4,77847 -3,86207
25 71,5 50,454 463 0 1,47E+12 2 3,87816 -4,25292
25 71,5 50,454 463 0 1,47E+12 2 4,08752 -2,91227
5 56,5 16,832 154 2,70E-68 2,02E+09 2 4,86315 -1,14895
21 41 85,559 727 0 3,16E+09 5 1,73976 1,72803
24 45,3 82,542 732 0 4,73E+09 9 1,60186 2,06119
24 45,3 82,542 732 0 4,73E+09 9 1,65103 2,25863
31 50,5 99,307 907 5,52E-255 3,58E+09 7 2,28587 -1,80947
12 20,1 86,454 755 2,56E-40 1,23E+09 2 2,22991 1,97993
3 20,7 25,172 227 2,05E-13 1,48E+08 2 1,78637 -1,26431
18 24,9 132,35 1223 1,27E-292 4,11E+09 2 1,29187 2,85267
18 24,9 132,35 1223 1,27E-292 4,11E+09 2 1,49732 3,35852
32 35,2 132,35 1223 0 9,76E+09 2 4,75764 5,88968
32 35,2 132,35 1223 0 9,76E+09 2 4,01952 5,24156
4 20,2 118,97 1078 1,49E-70 1,19E+09 1 3,41231 3,48915
6 39,2 20,14 189 9,51E-65 6,1E+08 3 1,88225 3,24187
21 59,6 54,356 507 0 1,31E+10 3 2,87414 1,35286
3 24,3 15,344 140 2,40E-09 1,57E+09 2 2,33547 -2,01504
21 44 71,343 616 1,70E-157 1,35E+09 14 3,19724 1,82998
21 44 71,343 616 1,70E-157 1,35E+09 14 3,39018 5,05066
21 44 71,343 616 1,70E-157 1,35E+09 14 3,62864 6,06094
21 44 71,343 616 1,70E-157 1,35E+09 14 2,84032 2,87424
1 64,6 63,974 551 0 4,82E+09 1 4,77253 4,22575
1 64,6 63,974 551 0 4,82E+09 1 4,14864 6,09188
1 64,6 63,974 551 0 4,82E+09 1 4,79667 7,11668
6 9,1 108,21 960 2,57E-66 5,43E+08 5 2,83393 -1,52363
3 10,3 65,223 585 5,01E-79 2,77E+08 2 2,238 -2,14546
6 10,7 107,5 1010 2,90E-171 6,44E+08 4 3,47367 -1,1054
8 26 41,31 358 8,26E-34 2,38E+09 2 1,53838 1,82033
2 81,6 85,299 770 0 8,8E+10 1 4,07654 4,42884
2 81,6 85,299 770 0 8,8E+10 1 3,09574 6,78048
2 81,6 85,299 770 0 8,8E+10 1 3,91528 8,21238
2 81,6 85,299 770 0 8,8E+10 1 3,17706 4,33958
2 81,6 85,299 770 0 8,8E+10 1 4,67284 5,21947
4 53 84,456 759 0 4,25E+09 5 3,546 4,8551
4 53 84,456 759 0 4,25E+09 5 4,62838 6,79143
4 53 84,456 759 0 4,25E+09 5 2,7875 4,78671
4 53 84,456 759 0 4,25E+09 5 4,16445 5,83498
3 60,2 40,084 354 0 1,81E+11 4 3,30128 1,33755
8 19,2 36,196 328 5,65E-114 3,87E+09 15 1,64422 2,14055
5 18 41,598 372 1,10E-36 3,17E+08 4 1,89053 -1,99452
16 68,7 25,238 217 1,76E-251 9,8E+09 6 1,72204 2,28355
9 8,9 170,39 1499 2,08E-90 1,39E+09 3 3,06805 4,51593
6 10,3 85,941 780 3,55E-48 1,51E+09 6 1,65377 1,37005
6 22,4 40,141 366 4,44E-27 3,01E+08 6 2,06964 -2,94796
11 26 81,83 730 7,47E-135 3,45E+09 2 2,17186 1,93898
8 24,9 62,22 486 4,60E-33 7,53E+08 5 3,73459 2,30845
25 79,7 40,064 356 1,53E-291 8,43E+09 3 2,66838 3,42744
25 79,7 40,064 356 1,53E-291 8,43E+09 3 2,49979 5,08798
25 79,7 40,064 356 1,53E-291 8,43E+09 3 1,94895 3,11059
8 73,5 10,963 102 1,82E-86 6,27E+09 2 1,49534 -2,16614
4 9,4 32,627 298 9,14E-66 2,74E+09 2 1,44344 -1,87298
6 20,8 48,493 423 3,48E-27 4,61E+08 3 2,95842 2,40648
17 22,8 138,97 1257 2,52E-211 1,83E+09 1 3,249 4,61787
17 22,8 138,97 1257 2,52E-211 1,83E+09 1 1,47904 2,90814
17 22,8 138,97 1257 2,52E-211 1,83E+09 1 4,59174 4,10973
16 19,3 138,97 1257 1,51E-55 1,27E+09 1 1,59656 2,21413
16 19,3 138,97 1257 1,51E-55 1,27E+09 1 2,14867 2,78299
5 4,6 162,83 1488 2,51E-56 5,51E+08 5 2,60718 3,43591
7 9,2 129,12 1195 2,95E-149 2,89E+09 3 2,3094 3,05917
7 9,2 129,12 1195 2,95E-149 2,89E+09 3 2,42799 3,92425
7 9,2 129,12 1195 2,95E-149 2,89E+09 3 2,32982 5,61018
7 9,2 129,12 1195 2,95E-149 2,89E+09 3 2,36335 4,01783
4 36,4 16,718 154 2,24E-211 1,94E+09 1 2,36976 -3,71076
2 16 338,88 2964 0 2,33E+09 15 2,25086 -2,68889
8 27,5 42,734 382 5,53E-158 1,38E+09 6 3,70927 -2,09099
8 16,3 83,86 743 2,76E-20 3,6E+08 7 2,00279 2,83154
3 20,9 18,955 172 1,55E-14 2,16E+09 1 3,13687 -2,31589
5 44,6 25,992 233 4,83E-246 7,06E+09 2 1,73329 2,46581
13 20 112,62 1036 5,06E-68 6,18E+08 1 3,66538 3,63819
13 20 112,62 1036 5,06E-68 6,18E+08 1 3,53781 3,76736
7 24,9 42,499 360 8,79E-20 1,18E+09 4 1,96731 1,3676
7 16,1 65,903 603 1,94E-52 9,34E+08 3 1,55117 1,62647
7 33,9 23,728 221 2,18E-49 6,43E+08 1 3,30795 4,66208
7 39,4 24,794 231 1,99E-119 8,81E+08 2 2,33729 -1,96068
7 22,3 117,43 1125 1,39E-98 7,01E+08 5 2,10164 -1,47647
5 17,1 37,392 334 4,70E-23 5,03E+08 3 2,26904 -1,96222
9 22,5 79,343 717 3,78E-68 5,99E+08 3 2,67203 -2,12627
7 30,3 25,535 228 1,43E-172 8,1E+09 2 1,51027 2,98477
13 8,9 220,45 545 1,65E-33 3,3E+08 24 2,66601 2,40971
7 27,7 46,575 423 3,43E-94 1,07E+09 3 2,87506 -1,89563
8 24,2 52,227 466 5,25E-37 5,66E+08 9 2,29149 -2,65538
3 72 7,9609 228 1,32E-98 8,49E+08 3 2,3611 2,49533
9 60,3 16,93 151 1,71E-67 2,6E+09 5 1,90277 1,9394
3 44,7 16,524 159 1,85E-127 7,11E+08 1 2,6832 2,81855
3 44,7 16,524 159 1,85E-127 7,11E+08 1 3,17252 4,31394
4 47,2 22,245 193 0 2,01E+09 4 3,5535 -3,32679
5 27,2 45,739 408 2,86E-46 1,36E+09 1 2,71532 -2,79752
13 44,4 45,739 408 7,18E-146 7,48E+09 2 2,31965 1,07187
59 57,6 129,51 1134 0 2,42E+10 6 3,1571 4,65073
59 57,6 129,51 1134 0 2,42E+10 6 3,75193 7,12015
8 86,6 9,3267 82 2,75E-74 6,75E+09 1 3,51553 -1,71332
7 50 19,992 172 3,31E-72 1,44E+09 1 2,82798 -2,98086
5 12,1 52,625 463 9,01E-23 2,06E+09 3 1,64398 2,17866
8 12,8 116,99 1090 3,45E-80 1,51E+09 2 2,40579 3,28841
13 55,9 21,825 195 5,13E-199 4,62E+09 4 3,15738 -4,05707
13 55,9 21,825 195 5,13E-199 4,62E+09 4 1,89064 -4,53279
13 55,9 21,825 195 5,13E-199 4,62E+09 4 3,25064 -3,8135
50 57,8 115,59 960 0 3,02E+10 6 2,81147 1,49593
50 57,8 115,59 960 0 3,02E+10 6 4,25599 2,31947
50 57,8 115,59 960 0 3,02E+10 6 3,76585 3,9406
50 57,8 115,59 960 0 3,02E+10 6 3,33407 2,64971
50 57,8 115,59 960 0 3,02E+10 6 2,67964 3,06783
14 45,1 55,832 486 3,94E-169 4,08E+09 2 2,80699 -4,79295
14 45,1 55,832 486 3,94E-169 4,08E+09 2 3,28943 -4,24254
24 77,6 60,607 544 0 1E+11 3 5,60417 3,31844
24 77,6 60,607 544 0 1E+11 3 3,5281 3,55587
24 77,6 60,607 544 0 1E+11 3 3,47697 4,01502
24 77,6 60,607 544 0 1E+11 3 3,39396 2,71056
24 77,6 60,607 544 0 1E+11 3 3,43991 3,77076
15 62,2 57,93 524 0 1,04E+10 1 2,84913 2,8981
15 62,2 57,93 524 0 1,04E+10 1 3,99631 4,02854
15 62,2 57,93 524 0 1,04E+10 1 3,75189 5,74434
15 62,2 57,93 524 0 1,04E+10 1 2,81544 5,12915
1 69,9 60,78 946 0 3,22E+10 3 2,45804 2,18338
1 69,9 60,78 322 0 3,22E+10 3 3,53515 2,28543
1 69,9 60,78 559 0 3,22E+10 3 3,30061 3,81772
1 69,9 60,78 744 0 3,22E+10 3 4,67771 3,69533
1 69,9 60,78 239 0 3,22E+10 3 3,18956 4,05273
8 22,3 64,622 593 7,90E-93 5,03E+08 1 3,29999 2,17747
2 6,7 74,866 682 3,85E-20 2,15E+08 1 2,59016 1,71249
7 17,2 80,947 719 4,51E-40 4,7E+08 2 3,83952 1,32685
5 32,1 37,333 346 1,77E-28 3,01E+08 4 1,55357 2,29267
5 32,1 37,333 346 1,77E-28 3,01E+08 4 1,81003 1,94067
4 28,2 23,277 220 4,90E-26 4,05E+08 1 2,83034 3,31099
4 24,7 17,348 150 4,46E-11 1,46E+09 2 2,47046 -1,07949
22 16,2 231,35 2105 4,64E-104 4,35E+09 4 1,85486 1,31779
11 15 121,71 1064 4,68E-47 3,4E+08 1 2,15058 3,0278
10 18,9 83,516 724 1,68E-62 1,13E+09 6 2,707 3,56346
10 18,9 83,516 724 1,68E-62 1,13E+09 6 2,76513 4,41627
10 18,9 83,516 724 1,68E-62 1,13E+09 6 3,65534 2,02467
10 18,9 83,516 724 1,68E-62 1,13E+09 6 3,18554 3,58478
6 26,7 47,318 416 4,99E-79 1,25E+09 2 1,34481 2,47812
18 23,7 105,01 946 1,90E-299 1,34E+09 3 2,43087 3,78972
13 17,5 105,01 946 1,13E-110 1,1E+09 3 1,83261 1,83358
13 17,5 105,01 946 1,13E-110 1,1E+09 3 2,38686 2,0211
8 40,5 36,314 321 3,10E-43 2,97E+09 3 2,06142 2,3423
5 13,7 54,388 488 4,42E-22 1,94E+09 1 1,38387 -2,55805
8 10,5 118,92 1073 1,41E-66 1,34E+09 4 1,97156 4,2035
30 29,6 118,92 1073 2,14E-200 2,15E+10 4 2,68414 3,36125
30 29,6 118,92 1073 2,14E-200 2,15E+10 4 2,53422 1,75801
5 5,2 231,37 2119 1,07E-64 2,98E+08 1 1,48115 2,92026
14 10,8 206,23 1842 5,08E-96 3,31E+09 3 2,60597 2,65876
6 37,2 30,114 261 7,00E-27 9,18E+08 2 3,60558 2,56669
16 37,8 56,379 513 3,19E-163 2,42E+09 7 2,63269 1,18545
4 29,7 37,54 330 7,06E-159 2,14E+09 2 2,93023 2,57198
14 26,5 88,337 780 2,90E-148 6,44E+08 3 2,71174 3,58895
14 26,5 88,337 780 2,90E-148 6,44E+08 3 4,1655 4,51262
5 20,4 60,824 524 1,05E-33 2,58E+09 5 1,50251 2,1335
6 8,8 184,93 1650 9,37E-37 4,48E+08 1 3,19444 -3,94763
8 15,9 77,221 674 2,88E-96 3,31E+08 5 2,18132 1,71266
8 15,9 77,221 674 2,88E-96 3,31E+08 5 1,69791 1,87488
3 4,5 101,22 971 3,53E-23 1,05E+09 1 3,1007 1,24475
5 16,2 43,76 390 6,19E-29 1,37E+09 10 1,46557 1,54184
5 26 27,372 246 2,23E-17 4,95E+08 3 2,81704 -1,92171
4 23,9 24,72 222 4,02E-14 3,71E+08 1 2,27088 1,84656
4 27,2 27,057 239 5,84E-17 8,9E+08 5 3,15285 1,4651
9 50 24,423 216 8,16E-280 5,3E+10 3 3,73274 -2,16769
9 50 24,423 216 8,16E-280 5,3E+10 3 2,46733 -1,80242
9 50 24,423 216 8,16E-280 5,3E+10 3 2,62782 -1,72239
6 42,4 20,825 184 2,74E-53 4,42E+09 3 1,76309 2,10246
27 59 66,076 607 0 4,62E+10 2 2,383 -1,98375
8 16,8 80,782 679 5,88E-88 5,61E+08 4 2,78589 3,53558
2 29,7 44,728 396 5,60E-207 7,02E+08 5 2,48757 2,2636
12 29,3 59,846 547 5,51E-124 1,5E+09 1 1,84948 2,6773
12 29,3 59,846 547 5,51E-124 1,5E+09 1 5,16327 3,51903
12 29,3 59,846 547 5,51E-124 1,5E+09 1 2,4611 1,95265
12 18,8 76,956 686 4,73E-24 2,19E+08 1 1,69557 2,04105
7 11,4 158,17 1354 6,41E-34 1,5E+08 2 1,66186 1,95278
71 55,5 160,61 1388 0 4,58E+10 5 1,70148 4,03564
71 55,5 160,61 1388 0 4,58E+10 5 1,99056 2,26665
71 55,5 160,61 1388 0 4,58E+10 5 2,48041 5,11748
71 55,5 160,61 1388 0 4,58E+10 5 3,72766 6,66399
59 43,8 166,88 1388 0 2,15E+10 5 4,45629 3,22498
59 43,8 166,88 1388 0 2,15E+10 5 2,40269 2,89005
3 27,3 14,759 128 1,29E-16 1,92E+09 2 2,14051 -2,19044
1 29,8 9,461 84 1,40E-61 8,43E+08 2 2,31643 -2,11114
12 35,6 61,557 564 0 1,65E+09 5 1,86834 2,28117
12 35,6 61,557 564 0 1,65E+09 5 1,50719 2,78953
4 12,4 63,012 564 8,62E-19 2,57E+08 5 3,1623 1,26275
4 19,1 38,586 350 2,89E-113 1,47E+09 3 1,8261 1,28197
3 16,3 47,129 429 6,72E-142 1,13E+09 4 2,41624 2,1921
14 46,2 54,935 478 4,63E-106 9,6E+08 9 1,96655 2,00679
20 58,6 50,648 437 0 4,29E+10 4 1,91506 1,61324
12 59,3 55,874 484 0 5,55E+09 8 1,76789 2,48995
13 25,9 79,375 696 2,27E-102 1,26E+09 1 1,98981 2,53203
13 25,9 79,375 696 2,27E-102 1,26E+09 1 4,71703 4,20948
13 25,9 79,375 696 2,27E-102 1,26E+09 1 2,66164 2,75257
4 7,8 93,446 892 9,27E-23 2,33E+08 6 2,54616 3,2279
3 17,5 34,166 320 6,53E-28 1,88E+08 3 1,76164 -2,1152
10 11,8 141,46 1233 3,75E-86 8,44E+08 3 1,47971 2,59183
14 28,2 91,85 901 0 7,56E+09 8 1,73499 2,89459
8 29,1 60,988 539 1,62E-39 1,88E+09 4 2,16773 1,77942
8 23,8 54,937 512 2,55E-40 2,51E+08 1 1,88766 1,89641
8 23,8 54,937 512 2,55E-40 2,51E+08 1 4,0622 3,23212
5 6,6 124,45 1099 2,97E-36 2,03E+08 5 1,91852 1,75187
2 36,7 55,72 504 8,55E-41 1,09E+09 4 1,51404 -2,09161
7 20,5 41,655 371 1,04E-64 6,81E+08 4 2,22178 3,21514
3 12,8 59,771 548 1,07E-09 3,05E+08 4 1,71872 -2,38329
3 17,5 37,066 326 3,14E-90 5,69E+08 6 1,76369 1,4445
5 21,1 33,053 284 1,05E-48 8,72E+08 2 2,67894 3,57202
1 24,5 25,977 2055 1,43E-46 1,2E+10 1 1,40755 -3,55848
9 12,9 119,96 1240 3,03E-87 1,87E+08 2 2,39243 1,89454
9 12,9 119,96 1240 3,03E-87 1,87E+08 2 2,89179 2,52665
13 12,9 192,56 1715 4,42E-133 6,76E+08 3 2,82945 -3,07947
4 8,4 74,455 669 1,32E-11 1,77E+08 4 1,77188 -2,31111
17 27,7 80,774 744 5,31E-281 8,67E+08 3 2,62151 2,62855
17 27,7 80,774 744 5,31E-281 8,67E+08 3 4,02197 3,89108
31 17,4 347,94 3102 0 4,08E+09 5 1,91357 -2,48628
20 41,6 68,489 603 0 2,47E+09 4 2,61827 4,09685
20 41,6 68,489 603 0 2,47E+09 4 3,24598 5,69973
20 41,6 68,489 603 0 2,47E+09 4 2,33981 5,97729
6 46,1 26,201 228 3,88E-79 3,98E+09 2 3,58273 3,34181
9 35,9 32,926 290 6,34E-100 1,71E+09 1 1,42193 1,97247
4 34,1 19,481 167 4,32E-32 1,05E+09 1 2,81691 -1,37308
24 50,6 61,508 559 0 2,14E+10 4 3,23029 4,27576
24 50,6 61,508 559 0 2,14E+10 4 3,2692 5,38568
24 50,6 61,508 559 0 2,14E+10 4 4,04126 2,12129
15 40,5 55,203 501 0 6,88E+09 2 3,52642 4,97187
15 40,5 55,203 501 0 6,88E+09 2 3,36055 6,40397
15 40,5 55,203 501 0 6,88E+09 2 3,23365 1,4132
32 68,9 54,274 501 0 2,89E+10 3 3,23215 2,33355
32 68,9 54,274 501 0 2,89E+10 3 4,48616 4,77987
32 68,9 54,274 501 0 2,89E+10 3 3,42644 5,66159
4 18,8 36,943 261 2,26E-19 4,01E+08 4 2,27024 -3,15362
6 18,5 50,08 493 8,13E-28 5,29E+08 2 3,70893 4,00003
29 78,9 46,297 440 0 1,55E+10 2 2,27212 3,99915
29 78,9 46,297 440 0 1,55E+10 2 3,98838 4,25088
29 78,9 46,297 440 0 1,55E+10 2 3,41332 5,13459
17 50,9 49,452 485 0 9,56E+09 4 3,96563 3,0361
17 50,9 49,452 485 0 9,56E+09 4 2,75699 3,64346
17 50,9 49,452 485 0 9,56E+09 4 4,59703 4,8972
12 62,7 35,316 322 7,31E-82 1,78E+09 1 4,80753 3,08332
2 29,7 70,406 1078 4,13E-74 1,76E+08 5 1,30407 1,77061
19 69,6 35,316 322 4,40E-187 7,63E+09 1 3,21491 3,13639
19 69,6 35,316 322 4,40E-187 7,63E+09 1 2,45817 1,65002
19 69,6 35,316 322 4,40E-187 7,63E+09 1 2,86812 1,38016




























































































































































Antibodies used in PLA 




Company Recommended by 
manufacturer for 
Reference link 




Rabbit 1:400 Sigma IF http://www.sigmaaldrich.com/catalog/produ
ct/sigma/hpa004798?lang=de&region=DE 
Cdc42 (B-8) Mouse 1:400 Santa Cruz IF https://www3.scbt.com/scbt/product/cdc42-
antibody-b-8 
Cdc42 (P-1) Rabbit 1:300 Santa Cruz IF https://www3.scbt.com/scbt/de/product/cd
c42-antibody-p1 
IQSEC3 Rabbit 1:400 Atlas antibodies   
Mzt2 (C-14) Rabbit 1:200 Santa Cruz IF https://www3.scbt.com/scbt/de/product/mz
t2a-b-antibody-c-14 
Opa1 (55772) Mouse 1:400 Abcam IF http://www.abcam.com/OPA1-antibody-
ab55772.pdf 
Rac1 (23A8) Mouse 1:500 Upstate IHC http://www.abcam.com/rac-antibody-23a8-
ab13048.html (immunohistochemistry) 
Rac1 (20571-1-AP) Rabbit 1:300 Proteintech ELISA http://www.ptglab.com/Products/RAC1-
Antibody-20571-1-AP.htm (ELISA) 
RhoA (26C4) Mouse 1:400 Santa Cruz IF https://www.scbt.com/scbt/product/rho-a-
antibody-26c4 
RhoA (119) Rabbit 1:300 Santa Cruz IF https://www.scbt.com/scbt/product/rho-a-
antibody-119 
Rock2 (1E12) Rabbit 1:200 Abnova IF http://www.novusbio.com/ROCK2-Antibody-
1E12_H00009475-M02.html 




Legends to Supplemental Figures and Tables 
 
Fig S1: GTPase activity of purified recombinant RhoA, Cdc42, and Rac1 under 
different conditions. GTPase activity was determined by monitoring GTP to GDP ratios 
over time by HPLC measurements. GTP-loaded GTPases were incubated with either 
buffer (greyline) or cell lysates of Citrine (green line) or Citrine-GAP (blue line) 
transfected cells. Samples were collected at different time intervals, immediately treated 
with TCA for protein precipitation and neutralized with NaOH. Guanine nucleotide ratios 
were determined by HPLC and relative GTP ratios calculated from GTP/(GTP+GDP). 
Rate constants (kcat) of intrinsic GTP hydrolysis were calculated from exponential fittings 
on the data. All three GTPases showed GTPase activity that was further stimulated by 
the respective GAP. 
 
Fig S2: LF-qGAP from brain lysates from additional tissues for (A) Rac1 (Cerebellum), 
(B) RhoA (Cerebellum) and (C) Cdc42 (Hippocampus). Specific interactors (colored in 
orange) are distinguished from background proteins based on a combination of the log2 
fold change and the t-test p-value. GTPγS-specific interactors are expected in the upper 
right corner, interactors of the GDP-form in the upper left corner. 
 
Fig S3: Validation of loading state dependent interactions in situ with the proximity 
ligation assay (PLA) (details given in Fig. 5A). This figure is complementary to figure 5.  
 
Fig S4: Fragment spectra of Rho GTPase interactors identified by only one peptide 
sequence. For each protein the best available spectrum of the corresponding peptide 
was selected. All spectra are shown in the mass to charge deconvoluted version as 
listed in the msms.txt as provided by MaxQuant. Red peaks belong to the y-ion series, 
blue peaks to the b-ion series and grey peaks are unidentified background peaks of 
each spectrum. Orange labels indicate a modification of the corresponding fragment. 
 
Table legends  
Supplemental Table 1: Interaction partners of Rho GTPases. For the six Rho GTPases 
RhoA, RhoB, RhoC, RhoD, Rac1 and Cdc42 a total number of 293 distinct interactions 
were identified with LF-qGAP. A number of interactions were identified repeatedly in 
different tissues. 
 
Supplemental Table 2: List of antibodies used for the proximity ligation assays. This 
list gives additional information about suppliers, used dilutions and reference links. 
 
